<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Essential Gene Identification Drug Target <br /> Prioritization Aspergillus fumigatus <br /> Wenqi Hu1, Susan Sillaots1, Sebastien Lemieux1&#194;&#164;, John Davison1, Sarah Kauffman2, Anouk Breton1, Annie Linteau1, <br /> Chunlin Xin1, Joel Bowman3, Jeff Becker2, Bo Jiang1, Terry Roemer1* <br /> 1 Merck Frosst Center Fungal Genetics, Montreal, Quebec, Canada, 2 Department Microbiology, University Tennessee, Knoxville, Tennessee, United States America, <br /> 3 Infectious Diseases, Merck Research Laboratories, Rahway, New Jersey, United States America <br />  <br />  <br /> Aspergillus fumigatus prevalent airborne filamentous fungal pathogen humans, causing severe often <br /> fatal invasive infections immunocompromised patients. Currently available antifungal drugs treat invasive <br /> aspergillosis limited modes action, safe effective. <span id='am-2' about='protege:TO' typeof='owl:Thing'>To</span> identify prioritize antifungal drug <br /> targets, developed conditional promoter replacement (CPR) strategy using nitrogen-regulated A. <br /> fumigatus NiiA promoter (pNiiA). The gene essentiality 35 A. fumigatus genes directly demonstrated this <br /> pNiiA-CPR strategy set 54 genes representing broad biological functions orthologs confirmed be <br /> essential growth Candida albicans Saccharomyces cerevisiae. Extending approach, the <br /> ERG11 gene family (ERG11A ERG11B) essential A. fumigatus despite member essential <br /> individually. In addition, demonstrate pNiiA-CPR strategy suitable vivo phenotypic analyses, a <br /> number conditional mutants, including ERG11 double mutant (erg11BD, pNiiA-ERG11A), failed establish a <br /> terminal infection immunocompromised mouse model systemic aspergillosis. Collectively, pNiiA-CPR <br /> strategy enables rapid reliable means directly identify, phenotypically characterize, facilitate target-based <br /> whole cell assays screen A. fumigatus essential genes cognate antifungal inhibitors. <br /> Citation: Hu W, Sillaots S, Lemieux S, Davison J, Kauffman S, et al. (2007) Essential gene identification drug target prioritization Aspergillus fumigatus. PLoS Pathog 3(3): <br /> e24. doi:10.1371/journal.ppat.0030024 <br />  <br />  <br />                                                                                               ing similar genetic approaches fungal pathogens has <br /> Introduction <br />                                                                                               proved dif&#239;&#172;?cult limited available molecular technol- <br />    Aspergillus fumigatus ubiquitous soil-dwelling sapro-                                 ogies asexual nature medically relevant <br /> phytic fungus propagates proli&#239;&#172;?c produc-                                     fungi, preventing use classical genetics. Nonetheless, <br /> tion air-borne conidia [1]. Large-scale genome                                             large-scale essential gene identi&#239;&#172;?cation Candida albicans has <br /> comparisons shown gene sets shared                                           begun number alternative approaches, including <br /> exclusively Aspergillus fumigatus human                                 antisense-based gene inactivation [8], transposon-based het- <br /> pathogenic fungi sequenced date, Candida                                        erozygote screens hypomorphs [9], homozygote null <br /> Cryptococcus species [2]. Thus, recently suggested                                mutants [10], promoter replacement strategy to <br /> that A. fumigatus pathogenesis based saprophytic                                    construct conditional mutants [11]. <br /> lifestyle combination immunosuppressed state of <br />                                                                                                  Large-scale functional analysis essential gene identi&#239;&#172;?ca- <br /> the host, genuine fungal virulence factors <br />                                                                                               tion A. fumigatus proved dif&#239;&#172;?cult. Although gene <br /> [2]. Although A. fumigatus conidia constantly inhaled and <br />                                                                                               disruption methodologies adapted A. fumigatus, <br /> seldom cause medical conditions healthy individ- <br />                                                                                               limited organism&#226;&#8364;&#8482;s poor ef&#239;&#172;?ciency of <br /> uals, immunocompromised patients (e.g., HIV <br />                                                                                               homologous recombination inherent inability to <br /> infection AIDS, solid organ bone marrow transplant <br /> recipients, receiving chemotherapy) highly                                      study essential genes means. A. fumigatus essential genes <br /> susceptible invasive aspergillosis, fatal systemic infection                             de&#239;&#172;?ned using parasexual genetics gene <br /> [1,3,4]. Current treatment options invasive aspergillosis <br /> are limited classes antifungal therapeutics:                                      Editor: Brendan P. Cormack, Johns Hopkins University School Medicine, United <br /> polyenes (amphotericin B various liposomal formula-                                       States America <br /> tions), azoles (e.g., &#239;&#172;&#8218;uconazole, voriconazole, itraconazole),                                Received May 9, 2006; Accepted January 8, 2007; Published March 9, 2007 <br /> and, recently, semisynthetic echinocandins (e.g., caspo- <br />                                                                                               Copyright: &#195;&#8220; 2007 Hu et al. This open-access article distributed the <br /> fungin anidulafungin) [4,5]. Despite current therapeutic                                  terms Creative Commons Attribution License, permits unrestricted <br /> options, mortality associated invasive aspergillosis                                     use, distribution, reproduction medium, provided original author <br />                                                                                               source credited. <br /> remains high (ranging 60% 90%) ef&#239;&#172;?ca- <br /> cious antifungal drugs novel mechanisms action                                    Abbreviations: ACM, Aspergillus complete medium; AMM, Aspergillus minimal <br />                                                                                               medium; CFU, colony-forming units; CPR, conditional promoter replacement; MIC, <br /> needed [4,5].                                                                                 minimum inhibitory concentration; pNiiA, A. fumigatus NiiA nitrogen-regulatable <br />    The identi&#239;&#172;?cation conserved essential genes required                                promoter; RT-PCR, reverse transcription PCR <br /> the growth fungal pathogens offers ideal strategy                                   * To correspondence addressed. E-mail: terry_roemer@merck. <br /> elucidating novel antifungal drug targets. A comprehensive                                    com <br /> determination essential genes achieved                                 &#194;&#164; Current address: Institute Research Immunology Cancer, Universite&#194;&#180; de <br /> the nonpathogenic yeast Saccharomyces cerevisiae [6,7]. Extend-                               Montre&#194;&#180;al, Montreal, Quebec, Canada <br />  <br />  <br />         PLoS Pathogens | www.plospathogens.org                                         0001                                          March 2007 | Volume 3 | Issue 3 | e24 <br />                                                                                                                        A. fumigatus Essential Gene <br />  <br />  <br /> Author Summary                                                                 fungal pathogens signi&#239;&#172;?cant relevance to <br />                                                                                antifungal drug discovery. <br /> Aspergillus fumigatus opportunistic filamentous fungal <br /> pathogen emerging clinical significance. Although virulence                 Results <br /> factors seen potential drug targets, genetic analyses <br /> nor genomic comparisons identified genuine virulence factors              Construction A. fumigatus Conditional Mutant by <br /> in A. fumigatus. Essential genes required fungal growth                Promoter Replacement <br /> viability serve potential drug targets,                 A. fumigatus conditional mutants constructed CPR <br /> described pathogen. To begin catalog essential genes A.          using pNiiA. pNiiA chosen based previous work in <br /> fumigatus, devised genetic strategy creating conditional <br />                                                                                A. fumigatus A. nidulans demonstrating tight <br /> mutants promoter replacement target genes using nitrogen- <br /> regulated promoter. Applying genetic approach A. fumigatus <br />                                                                                nitrogen-dependent transcriptional regulation [17,18]. Two <br /> genes orthologous known essential genes nonpathogenic                operationally independent signals control pNiiA expression: <br /> yeast, Saccharomyces cerevisiae Candida albicans, demon-                inducer (e.g., nitrate secondary nitrogen source) <br /> strate robust enrichment identifying essential genes conserved           repressor (e.g., ammonium primary nitrogen <br /> within pathogen. We A. fumigatus conditional                    source). Expression achieved solely absence of <br /> mutants evaluated according terminal phenotypes                ammonium presence nitrate; however, repression <br /> (e.g., conidial germination, growth, morphology, cidal versus              achieved presence ammonium regardless the <br /> static consequences) pathogenesis murine model                     presence nitrogen [17,18]. pNiiA-CPR mutants were <br /> systemic aspergillosis prioritize essential genes novel drug <br />                                                                                constructed homologous recombination-mediated dele- <br /> targets suitable developing broad-spectrum antifungal agents. <br />                                                                                tion endogenous promoter (approximately 250 <span id='am-705' about='xsp:base' typeof='owl:Thing'>base</span> <br />                                                                                pairs promoter sequence immediately preceding start <br />                                                                                codon gene) replacement NiiA promoter <br /> essentiality inferred failure recover haploid                   cassette marked pyrG selectable marker (Figure 1A <br /> segregants carrying gene <span id='am-393' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-394' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-395' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-396' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-397' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-398' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-399' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-400' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-401' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-402' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-403' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-404' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-405' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-406' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-407' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-408' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-409' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-410' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-411' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-412' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-413' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-414' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-415' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-416' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-417' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-418' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-419' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-420' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-421' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-422' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-423' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-424' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-425' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-426' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-427' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-428' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-429' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-430' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-431' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-432' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-433' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-434' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-435' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-436' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-437' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-438' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-439' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-440' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-441' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-442' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-443' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-444' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-445' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-446' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-447' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-448' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-449' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-450' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-451' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-452' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-453' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-454' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-455' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-456' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-457' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-458' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-459' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-460' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-461' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-462' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-463' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-464' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-465' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-466' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-467' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-468' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-469' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-470' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span>knock-out</span> [12,13]. Nevertheless,                    1B; Materials Methods details). To test the <br /> such approach likely unsuitable systematically identify               pNiiA-CPR strategy, TUB1 MET2 &#239;&#172;?rst selected. <br /> all possible essential genes irregularities para-                TUB1 encodes broadly conserved essential protein a- <br /> sexual cycle A. fumigatus. Direct demonstration A. fumigatus             tubulin, MET2 encodes homoserine O-acetyltransferase <br /> gene essentiality phenotypic analyses, however,                     involved methionine biosynthesis, mutations which <br /> achieved using molecular genetics strategies including RNA                     cause methionine auxotrophy. TUB1 MET2 pNiiA-CPR <br /> interference promoter replacement strategies [14,15].                       mutants displayed wild-type mycelial growth inducing <br /> Mouyna et al. (2004) used <span id='am-627' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-628' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-629' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-630' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-631' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-632' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-633' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-634' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-635' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-636' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-637' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-638' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-639' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-640' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-641' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-642' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-643' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-644' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-645' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-646' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-647' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-648' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-649' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-650' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-651' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-652' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-653' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-654' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-655' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-656' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-657' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-658' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-659' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-660' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-661' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-662' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-663' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-664' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-665' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-666' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-667' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-668' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-669' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-670' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-671' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-672' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-673' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-674' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-675' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-676' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-677' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-678' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-679' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-680' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-681' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-682' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-683' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-684' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-685' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-686' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-687' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-688' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-689' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-690' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-691' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-692' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-693' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-694' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-695' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-696' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-697' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-698' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-699' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-700' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-701' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-702' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-703' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-704' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span>RNA interference</span> produce                     medium (Aspergillus minimal medium [AMM] plus nitrate), <br /> the predicted phenotypes associated nonessential                   mutant able grow repressing medium <br /> gene involved melanin biosynthesis (alb1) essential                  (AMM plus ammonium, Figure 1C). Furthermore, A. <br /> glucan synthase, FKS1 [14]. (Note: In report, maintain                 fumigatus MET2 conditional mutant displayed tight methio- <br /> gene nomenclature A. fumigatus genes previously                         auxotrophy fully suppressed methionine <br /> described [e.g., alb1 FKS1]; cases previously                      added medium (Figure 2A). pNiiA-CPR conditional <br /> uncharacterized A. fumigatus genes described, standard S.                  mutants GFA1 ALR1, orthologs essential in <br /> cerevisiae gene nomenclature provisional gene names                    S. cerevisiae C. albicans, examined (Figure <br /> adopted according yeast ortholog.) To date, conditional               1C). GFA1, glutamine-fructose-6-phosphate aminotransfer- <br /> promoter replacement (CPR) strategies applied A. fumigatus                  ase catalyzing &#239;&#172;?rst step chitin biosynthesis pathway, <br /> have restricted heterologous promoters including                   shown essential A. fumigatus. However, CPR <br /> Aspergillus nidulans alcA promoter Escherichia coli tetracy-               mutants ALR1 (a metal cation transporter belonging a <br /> cline-regulated promoter [15,16].                                              gene family A. fumigatus) failed display growth defect <br />    Here report CPR strategy identify A. fumigatus                      repressing conditions, revealing ALR1 non- <br /> essential genes prioritize potential antifungal drug                    essential A. fumigatus (see below). <br /> targets. This strategy uses A. fumigatus NiiA nitrogen-                       According severity growth <span id='am-237' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-238' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-239' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-240' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-241' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-242' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-243' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-244' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-245' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-248' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-249' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-250' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-251' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-252' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-253' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-254' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-255' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-256' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-261' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-264' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-265' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-266' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-267' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-268' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-269' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-270' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-271' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-272' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-273' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-274' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-276' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-278' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-280' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-281' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-282' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-283' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-284' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-287' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-288' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-290' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-291' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-293' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-294' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-295' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-296' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-297' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-298' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-299' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-300' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-301' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-302' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-303' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-304' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-305' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-306' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-307' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-308' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-309' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-310' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-311' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-312' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-313' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-314' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span>phenotype</span> <br /> regulatable promoter (pNiiA) delete replace                         displayed CPR mutants repressing conditions, qualita- <br /> endogenous promoter selected genes. By applying                        tive scores assigned CPR mutants to <br /> strategy 54 A. fumigatus genes diverse biological                        classify terminal phenotype (Figure 1D). A 4&#195;&#190; shutoff <br /> functions orthologs known essential                        phenotype assigned strains (e.g., GFA1) that <br /> growth S. cerevisiae C. albicans, identi&#239;&#172;?ed 35                  completely fail grow repressing medium 48 h 30 <br /> genes essential mycelial growth, displaying                    8C. Similarly, 3.5&#195;&#190; 3&#195;&#190; shutoff phenotype used score <br /> cidal terminal phenotype. We demonstrate                         strains showed severe (e.g., PFS2) severe <br /> ERG11 gene family essential A. fumigatus                    (e.g., ALG7) growth phenotype, respectively. Other growth <br /> resulting pNiiA-CPR strains used cell-based                    defects scored 2&#195;&#190; (mild), 1&#195;&#190; (minor; e.g., CDC24), 0&#195;&#190; <br /> cell assays examine target-speci&#239;&#172;?c chemical hypersensitiv-                  (no defect; e.g., ALR1). All essential genes described here <br /> ity. Finally, number pNiiA-CPR mutants                    showed complete absence growth (4&#195;&#190;) dramatic <br /> essential genes fail establish terminal aspergillosis                     growth defect (3.5&#195;&#190; 3&#195;&#190;) repressing conditions. <br /> infection mouse model system. Therefore, vitro <br /> and vivo phenotypic analysis essential genes                      Evaluating pNiiA-CPR Reliability Genetic Approaches <br /> performed. This initial gene set comprises experimentally                     To test reliability, pNiiA-CPR strategy further <br /> validated drug target set broadly conserved                     applied multiple A. fumigatus genes null phenotype <br />  <br />       PLoS Pathogens | www.plospathogens.org                            0002                                March 2007 | Volume 3 | Issue 3 | e24 <br />                                                                                                                                  A. fumigatus Essential Gene <br />  <br />  <br />  <br />  <br />                                                                                      Figure 2. Genetic Evaluation pNiiA-CPR Strategy <br />                                                                                      (A) Phenotypes pNiiA-CPR mutants HIS3, TRP5, MET16, MET2, LYS9, <br /> Figure 1. Outline A. fumigatus pNiiA-CPR Strategy                             LYS4. Under standard repressing conditions (Re, AMM plus <br /> (A) A cloning vector, pPyrG-pNiiA, created specifically                  ammonium), strains lacked detectable growth (4&#195;&#190; phenotype). <br /> construction CPR cassettes. This plasmid contains A. niger pyrG                Growth unimpaired inducing conditions (In; AMM plus <br /> (encoding orotidine-59-phosphate decarboxylase required                      nitrate). Growth phenotypes pNiiA-CPR mutants repressing <br /> uridine-uracil prototrophy) selection marker [41],                conditions specifically suppressed cognate amino acid was <br /> Amp&#195;&#190; selection marker A. fumigatus pNiiA conditional promoter.               provided growth media (His, histidine; Trp, tryptophan; Met, <br /> Unique restriction sites engineered pyrG-            methionine; Lys, lysine). <br /> pNiiA cassette facilitate subcloning flanking sequences.                       (B) Growth phenotypes pNiiA-CPR mutants previously reported <br /> (B) Schematic overview pNiiA-CPR strategy strain confirmation             A. fumigatus essential genes, FKS1, GUS1, SPE2, HEM15 [12,13]. <br /> by PCR genotyping. Promoter replacement cassettes constructed                   Reproducible 4&#195;&#190; essential growth phenotypes observed each <br /> by inserting approximately 1.5 kb homologous flanking sequences                pNiiA-CPR mutant repressing conditions exception of <br /> the target gene (L-arm R-arm) Not1/Mlu1 Asc1/Pac1                   FKS1, produced 3.5&#195;&#190; growth phenotype. <br /> restriction sites, respectively. After Not1 Pac1 double digestion,           (C) arp2 ayg1 conidial color phenotypes pNiiA-CPR strategy. <br /> linearized pNiiA-CPR cassette introduced CEA17 strain (pyrG )               Wild-type (WT) strain CEA10, pNiiA-arp2, pNiiA-ayg1 mutants display <br /> by protoplast transformation. As indicated, sets primers               normal dark-green conidia color inducing conditions. Gene- <br /> used perform genotypic PCRs map expected promoter                          specific conidia color phenotypes characteristic known null <br /> replacement junctions (L1/L2 left-arm junction, R1/R2 right-arm              phenotype [19] specifically detected repressing conditions. <br /> junction) confirm deletion native promoter (L1/P).                 (D) nudC growth phenotype pNiiA-CPR strategy. Highly <br /> (C) Phenotype transformants obtained pNiiA-CPR strategy                reproducible growth morphological phenotypes associated with <br /> MET2, TUB1, GFA1, ALR1. CPR mutants examined pNiiA-                   nudC mutants observed (see Figure S1) similarly determined using <br /> inducing (AMM plus nitrate) repressing (AMM plus ammonium)                       alcA heterologous conditional promoter [15]. <br /> conditions 36 h 30 8C.                                                      doi:10.1371/journal.ppat.0030024.g002 <br /> (D) Growth phenotypes GFA1, PFS2, ALG7, CDC24, ALR1 pNiiA-CPR <br /> mutants standard repressing conditions scored <br /> qualitatively following: 4&#195;&#190;, essential cell viability, growth <br />                                                                                      (ayg1 arp2) involved conidial pigmentation null <br /> under repressing conditions; 3.5&#195;&#190; 3&#195;&#190;, showing strong strong               phenotypes result production yellow-green and <br /> growth defect; 2&#195;&#190; 1&#195;&#190;, mild minor growth defect; 0&#195;&#190;, growth              pink-red conidiospores, respectively [19]. Hence, conidial <br /> phenotype observed. <br /> doi:10.1371/journal.ppat.0030024.g001                                                pigmentation phenotypes ayg1 arp2 mutants serve as <br />                                                                                      cell reporters monitor level repression <br /> was known independently veri&#239;&#172;?ed means.                            achieved pNiiA-CPR system. Indeed, pNiiA-ayg1 and <br /> First, pNiiA-CPR mutants constructed &#239;&#172;?ve genes                              pNiiA-arp2 conidia color shifted dark-green (wild-type <br /> (HIS3, TRP5, MET16, LYS9, LYS4) involved amino acid                           conidia color) inducing conditions yellow-green <br /> biosynthesis. Growth completely impaired strains                         (ayg1) red-pink (arp2) repressing conditions (Figure <br /> under repressing conditions lacking amino acids fully                            2C). Finally, applied pNiiA-CPR strategy A. fumigatus <br /> restored cognate amino acid provided (Figure                            nudC, gene shown essential promoter replacement <br /> 2A). Second, pNiiA-CPR mutants constructed                             A. nidulans alcA promoter [15]. Consistent previous <br /> genes (FKS1, GUS1, SPE2, HEM1) essentiality A.                          report [15], pNiiA-nudC mutant displayed (1) essential <br /> fumigatus demonstrated parasexual genetic                              growth phenotype (Figure 2D), (2) germination defect of <br /> strategy [12,13]. In instance, conditional mutant                           conidia approximately 70% conidia failing to <br /> displayed essential growth phenotype (Figure 2B). Third,                          germinate approximately 30% conidia forming short <br /> we constructed pNiiA-CPR mutants nonessential genes                           growth-arrested germ tubes (Figure S1), (3) nudC <br />  <br />        PLoS Pathogens | www.plospathogens.org                                 0003                                    March 2007 | Volume 3 | Issue 3 | e24 <br />                                                                                                                                               A. fumigatus Essential Gene <br />  <br />  <br />  <br /> Table 1. Comparison Growth Phenotypes Observed pNiiA- <br /> CPR Methods versus Gene <span id='am-471' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-472' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-473' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-474' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-475' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-476' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-477' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-478' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-479' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-480' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-481' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-482' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-483' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-484' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-485' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-486' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-487' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-488' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-489' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-490' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-491' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-492' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-493' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-494' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-495' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-496' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-497' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-498' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-499' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-500' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-501' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-502' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-503' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-504' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-505' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-506' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-507' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-508' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-509' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-510' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-511' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-512' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-513' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-514' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-515' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-516' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-517' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-518' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-519' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-520' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-521' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-522' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-523' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-524' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-525' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-526' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-527' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-528' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-529' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-530' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-531' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-532' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-533' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-534' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-535' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-536' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-537' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-538' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-539' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-540' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-541' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-542' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-543' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-544' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-545' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-546' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-547' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-548' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span>Knockout</span> <br />  <br /> A. fumigatus        Growth               Number Viable            Reproducible <br /> Gene                Phenotype            <span id='am-81' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-82' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-83' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-89' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-97' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-102' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-112' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-121' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-130' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-138' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span>Null Mutants</span>                Growth <br />                     pNiiA-CPR         Recoveredb                  Phenotype <br />                     Mutanta <br />  <br /> ERG11A              0&#195;&#190;                   4/23c                       Yes,   viable <br /> ERG11B              0&#195;&#190;                   2/23                        Yes,   viable <br /> ERG27               0&#195;&#190;                   1/12                        Yes,   viable <br /> ROM2                0&#195;&#190;                   1/15                        Yes,   viable <br /> LUC7                4&#195;&#190;                   0/107                       Yes,   essential <br /> TOM40               4&#195;&#190;                   0/84                        Yes,   essential <br /> MET2                4&#195;&#190;                   3/24d                       Yes,   auxotroph <br />  <br />  <br /> a <br />   Phenotypes examined standard pNiiA-repressing conditions, qualitative <br /> shutoff phenotype shown. <br /> b <br />   Demonstrated viability inferred essentiality null phenotype shown. <br /> c <br />  Number viable null mutants identified versus number transformants screened <br /> by PCR genotyping (e.g., 4/23 reflects confirmed, viable null mutants obtained <br /> among 23 transformants examined). <br /> d <br />   Viable deletion mutants identified plating methionine-supplemented medium. <br /> doi:10.1371/journal.ppat.0030024.t001 <br />                                                                                                 Figure 3. Expressional Level Analysis pNiiA-CPR Mutants <br /> nuclear distribution terminal phenotype characterized                                        (A) RT-PCR pNiiA-MET2: (a) pNiiA-MET2 mutant inducing <br /> multinucleate conidia (Figure S1).                                                              conditions, (b) pNiiA-MET2 mutant repressing conditions plus <br />                                                                                                 100 lg/ml methionine, (c) pNiiA-MET2 mutant inducing condition <br />   An advantage use large homologous &#239;&#172;&#8218;anking                                           plus 100 lg/ml methionine, (d) wild-type A. fumigatus strain (CEA10) <br /> sequences pNiiA-CPR cassettes multiple independ-                                     repressing conditions. To monitor ensure sample <br /> ent promoter replacement mutants recovered                                       loading, RT-PCRs ACT1 transcript performed using <br />                                                                                                 identical samples. In addition, standard PCR performed confirm <br /> given gene. Thus, gene essentiality independently                                        detectable genomic-DNA contamination. <br /> validated multiple pNiiA-CPR mutants. Indeed, multiple                                     (B) Northern blot analysis pNiiA-ALR1 mutant expression levels. <br /> independent pNiiA-CPR mutants (n . 2) recovered                                        Northern blot performed RNA samples prepared the <br />                                                                                                 nonessential ALR1 mutant wild-type cells growing standard <br /> 18 19 genes mentioned above, cases,                                     inducing (In) repressing (Re) conditions. ACT1 transcript levels served <br /> independent pNiiA-CPR mutants displayed reproducible                                            sample loading controls. <br /> growth phenotypes repressing conditions. Although                                         (C) Real-time RT-PCR analysis expression level pNiiA-ALR1 pNiiA- <br /> the essential growth phenotype GUS1 based                                         MET2. pNiiA-CPR mutants wild-type strain (CEA10) grown in <br />                                                                                                 inducing (In) repressing (Re) medium 37 8C 20 h, total RNA <br /> single pNiiA-GUS1 mutant recovered, essentiality                                         extracted identical time points. The relative expression level <br /> consistent previous work predicted function                                   normalized total input RNA [43] displayed y-axis. Error bars <br /> as glutamate-tRNA sythetase [13].                                                             represent SD. Compared wild-type, relative expression level for <br />                                                                                                 ALR1 MET2 0.013 0.061 repressing conditions 2.49 <br />                                                                                                 23.58 inducing conditions, respectively. <br /> Direct Comparison pNiiA-CPR Gene                                                    (D) pNiiA-TUB1 expression level inducing (In) repressing (Re) <br /> Disruption Terminal Phenotypes                                                                  conditions versus wild-type level displayed y-axis. Error bar <br />   Reliability pNiiA-CPR assessed pyrG-                                represents SD. The relative expression level pNiiA-TUB1 versus wild- <br />                                                                                                 type 0.06 repressing conditions 6.35 inducing <br /> based gene disruption multiple genes shown essential                                   conditions, respectively. Note: Since real-time RT-PCR performed <br /> by pNiiA-CPR approach (Table 1). In fact, viable null                                       using primers detecting pNiiA-TUB1 wild-type allele, data <br /> mutants ERG11A, ERG11B, ERG27, ROM2, MET2 (when                                          shown calculated subtracting wild-type level total inducing <br />                                                                                                 (In) total repressing (Re) level, respectively. <br /> exogenous methionine provided) recovered, consis-                                      doi:10.1371/journal.ppat.0030024.g003 <br /> tent nonessential conditional essential phenotypes <br /> determined pNiiA-CPR mutants. Moreover, viable null                                       described genes Table 1. As pNiiA-MET2 mutants grow <br /> mutants recovered TOM40 LUC7 gene <br />                                                                                                 normally repressing media supplemented methionine, <br /> disruption (two essential genes identi&#239;&#172;?ed pNiiA-CPR <br />                                                                                                 MET2 mRNA expression assessed inducing <br /> approach) despite signi&#239;&#172;?cantly large number transform- <br />                                                                                                 pNiiA-repressing conditions RT-PCR. MET2 mRNA <br /> ants examined (84 TOM40 107 LUC7, respectively) <br />                                                                                                 detected pNiiA-MET2 mutant wild-type <br /> (Table 1). Thus, essentiality TOM40 LUC7 shown by <br />                                                                                                 CEA10 inducing medium; however, MET2 transcript <br /> both pNiiA-CPR strategy gene deletion analysis. <br /> Collectively, data demonstrate robust genetic                                        detected pNiiA-MET2 mutant repressing <br /> conclusions spanning extensive set &#226;&#8364;&#732;&#226;&#8364;&#732;phenotypic reporter                                  medium supplemented methionine (Figure 3A). Sim- <br /> genes&#226;&#8364;&#8482;&#226;&#8364;&#8482; reliably reproduced pNiiA-CPR strategy.                                      ilarly, mRNA transcripts detected RT-PCR CEA10 <br />                                                                                                 pNiiA-CPR mutants ERG11A, ERG11B, ERG27, ALR1, <br /> Quantitative Analysis pNiiA-CPR Transcriptional                                              ROM2 inducing conditions pNiiA- <br /> Regulation                                                                                      CPR mutants maintained repressing conditions (Figure <br />  Reverse transcription (RT)-PCR &#239;&#172;?rst performed                                           S2). In addition, Northern blot analysis con&#239;&#172;?rmed a <br /> monitor pNiiA-CPR gene expression levels previously                                     signi&#239;&#172;?cant depletion ALR1 mRNA levels repressing <br />  <br />          PLoS Pathogens | www.plospathogens.org                                          0004                                     March 2007 | Volume 3 | Issue 3 | e24 <br />                                                                                                                    A. fumigatus Essential Gene <br />  <br />  <br /> conditions (despite lack clear growth phenotype)                  functions including lipid, ergosterol, cell wall, amino acid, <br /> versus endogenous level expression wild-type CEA10               protein, heme biosynthesis, glycosylation, <br /> (Figure 3B). Although ALR1 mRNA levels ALR1                     secretion, RNA processing, novel genes unknown <br /> conditional mutant clearly elevated compared                   functions (Table 2). Moreover, genes displaying <br /> wild-type, deleterious growth phenotype detected                    essential phenotype S. cerevisiae C. albicans and <br /> (Figure 1C).                                                               predicted single ortholog A. fumigatus (n &#194;&#188; <br />    Real-time RT-PCR performed evaluate                  44), 32 genes (73%) experimentally demonstrated as <br /> achievable range expression levels pNiiA-CPR                  sharing conserved growth phenotype 3&#195;&#190; greater A. <br /> mutants shown yield nonessential (ALR1),                     fumigatus. <br /> conditional essential (MET2), essential (TUB1) terminal                 Essential genes identi&#239;&#172;?ed manner constitute a <br /> phenotype (Figure 3C 3D). Compared wild-type, ALR1                  collection possible antifungal drug targets, micro- <br /> and MET2 expression levels CPR mutants dramati-                    scopic examination terminal growth phenotypes may <br /> cally reduced 75.9-fold 16.3-fold repressing                  assist prioritization (Figure 4). For example, <br /> conditions elevated 2.8-fold 23.6-fold                    repression GFA1 produced enlarged highly disrupted <br /> inducing conditions, respectively (Figure 3C). To overcome                 nongerminating conidia failed undergo polarized <br /> the technical dif&#239;&#172;?culty performing real-time RT-PCR                  growth. As GFA1 predicted encode sole glutamine- <br /> an essential gene, TUB1 tandem duplication mutant                    fructose-6-phosphate aminotransferase activity responsible <br /> constructed pNiiA-TUB1 allele balanced                &#239;&#172;?rst rate-limiting step chitin synthesis, this <br /> wild-type TUB1 copy control native                        terminal phenotype likely re&#239;&#172;&#8218;ects normal interdepend- <br /> promoter. Thus, expression pNiiA-regulated TUB1                     ence cell wall biosynthesis polarized growth. <br /> allele monitored repressing conditions (see                 Conidia SEC31 SLY1 incubated repressing <br /> Materials Methods). Real-time RT-PCR performed                    conditions unable germinate, suggesting these <br /> this strain revealed expression pNiiA-TUB1 allele             genes required initiation germ tubes, whereas <br /> approximately 0.06-fold repressed 6.3-fold                  terminal phenotypes TUB1, ERG10, and, promi- <br /> inducing conditions relative normal TUB1 expression                     nently, PRI1, resulted growth-arrested germ tubes. Inter- <br /> levels (Figure 3D). Collectively, data demonstrate              esting, HEM15 displayed complex terminal phenotype <br /> the pNiiA-CPR strategy typically achieves tight regulatable                dramatically swollen conidia single multiple germ <br /> expression suggest reliably applied                tubes. Repression pNiiA-FKS1 yielded stubby highly <br /> large-scale analysis gene essentiality A. fumigatus.                 branched micromycelial germlings morphologically <br />                                                                            resemble chemotype observed A. fumigatus treated <br /> Large-Scale Identification Essential Genes                              Fks1p-speci&#239;&#172;?c inhibitors caspofungin and <br />   The genomic sequence A. fumigatus strain AF293 [20],               related echinocandins [21]. Thus, distinct terminal pheno- <br /> well second clinical isolate used study, CEA10,               types identi&#239;&#172;?ed pNiiA-CPR mutants, some <br /> where approximately 103 coverage obtained (N.                     instances, appear severe caused either <br /> Fedorova, V. Joardar, J. Crabtree, M. Anderson, R. Maiti, et al.,          genetic chemical inactivation FKS1. <br /> unpublished data), provides opportunity systematically                  Essential genes cidal terminal phenotype are <br /> identify essential genes. Although global annotation A.             commonly preferred genetic evidence predicts that <br /> fumigatus genome ongoing, homologs genes                 chemical inhibitors targets display similar <br /> were identi&#239;&#172;?ed search alignment tools corre-                   chemotypes. An assay evaluate cidal static terminal <br /> sponding promoter replacement cassettes designed accord-                   phenotypes applied essential genes displaying 3.5&#195;&#190; or <br /> ingly. In total, 54 A. fumigatus genes selected pNiiA-            4&#195;&#190; growth phenotype (Table 2) incubating conidia in <br /> CPR analysis, 49 known essential (or                    pNiiA-repressing medium various durations time <br /> conditionally essential) growth S. cerevisiae          washing plating conidia pNiiA-inducing <br /> three essential normal growth C. albicans            medium viability scored counting colony- <br /> (Table 2). In addition, genes selected represent           forming units (CFU) (see Materials Methods Figure <br /> broad diversity gene functions cellular processes.                  5). Of 28 genes tested, genes (approximately 21%), <br /> Biasing A. fumigatus gene set essential               including GFA1 (Figure 5), displayed cidal terminal <br /> both S. cerevisiae C. albicans builds previous work                 phenotype, scored signi&#239;&#172;?cant reduction (greater than <br /> demonstrating 60% C. albicans genes                       90%) CFU 24-h incubation repressing medium. <br /> homologous essential S. cerevisiae genes                    Additional genes demonstrating cidal terminal phenotype <br /> essential C. albicans [11]. Therefore, reasoned               include KRR1, SEC31, SLY1, TUB1, GUS1 (Table 2). <br /> set genes experimentally demonstrated essential               Additional genes displayed slow cidal phenotype, scored <br /> distinct hemiascomycetes highly enriched genes                signi&#239;&#172;?cant reduction (greater 90%) CFU 48- <br /> sharing conserved essential functions euascomy-                 72-h incubation repressing medium, static terminal <br /> cetes.                                                                     phenotype 48-h incubation repressing conditions as <br />   Analysis A. fumigatus gene set revealed 35 genes                 shown TRR1 (Figure 5, Table 2). <br /> displaying 3&#195;&#190; greater (3.5&#195;&#190; 4&#195;&#190;) essential growth <br /> phenotype (Table 2). Excluding genes involved amino acid                The ERG11 Gene Family Is Essential A. fumigatus <br /> biosynthesis, signi&#239;&#172;?cant differences terminal growth                   Identifying gene families essential growth <br /> phenotypes observed minimum medium                            viability A. fumigatus missed approach <br /> (AMM) rich medium (Aspergillus complete medium                         require additional considerations. For example, <br /> [ACM]). Essential genes comprise spectrum biological                  duplicate ERG11 genes (encoding 14a-demethylase, the <br />  <br />       PLoS Pathogens | www.plospathogens.org                        0005                                March 2007 | Volume 3 | Issue 3 | e24 <br />                                           Table 2. Growth Phenotypes A. fumigatus Gene Set Examined Concordance Gene Essentiality C. albicans S. cerevisiae <br />  <br />                                          Biological Process           Gene     Gene Description S. cerevisiae                  GenBank     S. cerevisiae   C. albicans   Number      A. fumigatus   A. fumigatus   Cidal/Static <br />                                                                       Name                                                        Accession   Null Mutant     Phenotypec    A. fumigatus   Phenotype      Phenotype      Phenotype <br />                                                                                                                                   Numbera     Phenotypeb                    pNiiA-CPR      AMM &#195;&#190;       ACM &#195;&#190;e <br />                                                                                                                                                                             Mutants        Ammonium <br />                                                                                                                                                                             Recoveredd <br />  <br />                                          Amino acid biosynthesis      HIS3     Imidazole-glycerol-phosphate (IGP) dehydratase     XP_747608   Viablef         NAg           2              4&#195;&#190;             0&#195;&#190;             Static <br />                                                                       LYS4     Homoaconitate hydratase                            XP_753748   Viablef         4&#195;&#190;            2              4&#195;&#190;             0&#195;&#190;             Static <br />                                                                       LYS9     Saccharopine dehydrogenase                         XP_751695   Viablef         4&#195;&#190;            4              4&#195;&#190;             0&#195;&#190;             Static <br />                                                                       MET16    39-Phospho-adenylylsulfate reductase               XP_754952   Viablef         3&#195;&#190;            1              4&#195;&#190;             0&#195;&#190;             Static <br />                                                                       MET2     Homoserine O-acetyl-transferase                    XP_753913   Viablef         4&#195;&#190;            2              4&#195;&#190;             0&#195;&#190;             Slow cidal <br />                                                                       TRP5     Tryptophan synthase                                XP_755657   Viablef         4&#195;&#190;            2              4&#195;&#190;             0&#195;&#190;             Static <br />                                          Cell redox homeostasis       TRR1     Thioredoxin reductase                              XP_751532   Lethal          4&#195;&#190;            1              3.5&#195;&#190;           3.5&#195;&#190;           Static <br />                                          Cell wall organization   CHS2h    Chitin synthase II                                 XP_746604   Viable          3.5&#195;&#190;          3              1&#195;&#190;             1&#195;&#190;             NDi <br />  <br />  <br />  <br />  <br /> PLoS Pathogens | www.plospathogens.org <br />                                          biogenesis <br />                                                                       EXG1     Exo-b-1,3-glucanase                                XP_750110   Viable          3&#195;&#190;            4              0&#195;&#190;             0&#195;&#190;             NDi <br />                                                                       FKS1 h   b-1,3-Glucan synthase                              XP_751118   Viablej         4&#195;&#190;            2              3.5&#195;&#190;           3.5&#195;&#190;           Static <br />                                                                       GFA1     Glutamine-fructose-6-phosphate amino-transferase   XP_750525   Lethal          4&#195;&#190;            2              4&#195;&#190;             4&#195;&#190;             Cidal <br />                                                                       ROT1     Suppressor tor2 <span id='am-315' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-316' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-317' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-318' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-319' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-320' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-321' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-322' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-323' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-324' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-325' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-326' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-327' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-328' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-329' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-330' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-331' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-332' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-333' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-334' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-335' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-336' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-337' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-338' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-339' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-340' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-341' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-342' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-343' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-344' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-345' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-346' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-347' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-348' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-349' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-350' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-351' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-352' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-353' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-354' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-355' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-356' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-357' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-358' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-359' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-360' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-361' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-362' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-363' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-364' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-365' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-366' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-367' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-368' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-369' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-370' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-371' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-372' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-373' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-374' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-375' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-376' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-377' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-378' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-379' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-380' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-381' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-382' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-383' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-384' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-385' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-386' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-387' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-388' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-389' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-390' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-391' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-392' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span>mutation</span>                        EF207613    Lethal          3&#195;&#190;            2              0&#195;&#190;             0&#195;&#190;             NDi <br />                                          Cellular metabolism          AUR1     Phosphatidyl- inositol:ceramide phosphoinositol    XP_754623   Lethal          4&#195;&#190;            2              4&#195;&#190;             4&#195;&#190;             Static <br />                                                                                transferase <br />                                                                       CDS1     CDP-diacylglycerol (CDP-DAG) synthase              XP_750449   Lethal          4&#195;&#190;            2              4&#195;&#190;             4&#195;&#190;             Slow cidal <br />                                                                       HEM15    Ferrochelatase                                     XP_753861   Viablek          l            2              4&#195;&#190;             4&#195;&#190;             Static <br />                                                                       IPP1     Inorganic pyrophosphatase                          XP_754776   Lethal          4&#195;&#190;            2              3&#195;&#190;             3&#195;&#190;             NDi <br />  <br />  <br />  <br />  <br /> 0006 <br />                                                                       OLE1     Stearoyl-CoA desaturase                            XP_748918   Lethal          4&#195;&#190;            6              4&#195;&#190;             4&#195;&#190;             NDi <br />                                                                       SPE2     S-Adenosyl-methionine decarboxylase                XP_747977   Viablek         0&#195;&#190;            2              3.5&#195;&#190;           3.5&#195;&#190;           NDi <br />                                          Cytoskeleton organization    TUB1     Tubulin a-1 chain                                  XP_750005   Lethal          4&#195;&#190;            3              4&#195;&#190;             4&#195;&#190;             Cidal <br />                                          biogenesis <br />                                          DNA replication              ORC2     Origin recognition complex                         XP_753825   Lethal          3.5&#195;&#190;          2              0&#195;&#190;             0&#195;&#190;             NDi <br />                                                                       PRI1     DNA primase small subunit                          XP_754716   Lethal          4&#195;&#190;            2              4&#195;&#190;             4&#195;&#190;             Static <br />                                          Ergosterol biosynthesis      ERG10    Acetyl-CoA acetyl-transferase                      XP_747207   Lethal          4&#195;&#190;            2              4&#195;&#190;             4&#195;&#190;             Static <br />                                                                       ERG11h   Lanosterol 14a-demethylase                         XP_752137   Lethal          3.5&#195;&#190;          4              0&#195;&#190;             0&#195;&#190;             NDi <br />                                                                       ERG12    Mevalonate kinase                                  XP_752047   Lethal          4&#195;&#190;            4              3&#195;&#190;             3&#195;&#190;             NDi <br />                                                                       ERG27    3-keto-Sterol reductase                            XP_751680   Lethal          4&#195;&#190;            4              0&#195;&#190;             0&#195;&#190;             NDi <br />                                          Signal transduction          CDC24    GTP-GDP exchange factor Cdc42p                 XP_751685   Lethal          3.5&#195;&#190;          5              1&#195;&#190;             1&#195;&#190;             NDi <br />                                                                       ROM2     GDP-GTP exchange factor                            XP_753782   Lethal          3.5&#195;&#190;          8              0&#195;&#190;             0&#195;&#190;             NDi <br />                                          Ion transport                ALR1h    Putative cytoplasmic magnesium cobalt          XP_754049   Lethal          4&#195;&#190;            9              0&#195;&#190;             0&#195;&#190;             NDi <br />                                                                                transporter <br />                                          Protein modification         ALG11    Protein required N-linked oligosaccharide      XP_750438   Lethal          3&#195;&#190;            3              2&#195;&#190;             2&#195;&#190;             NDi <br />                                                                                assembly <br />                                                                       ALG7     UDP-N-acetyl-glucosamine-1-P transferase           XP_755457   Lethal          4&#195;&#190;            3              3&#195;&#190;             3&#195;&#190;             NDi <br />                                                                       GPI16    Protein subunit GPI transamidase                XP_750790   Lethal          3.5&#195;&#190;          5              2&#195;&#190;             2&#195;&#190;             NDi <br />                                          Protein translation          GCD6     Translation initiation factor eIF2B                XP_751131   Lethal          3.5&#195;&#190;          3              4&#195;&#190;             4&#195;&#190;             Slow cidal <br />                                                                       GUS1     Glutamyl-tRNA synthetase                           XP_747988   Lethal          4&#195;&#190;            1              4&#195;&#190;             4&#195;&#190;             Cidal <br />                                                                       NIP1     Subunit translation initiation complex eIF3     XP_746573   Lethal          4&#195;&#190;            2              0&#195;&#190;             0&#195;&#190;             NDi <br />                                                                       PAB1     Poly(A)-binding protein cytoplasm nucleus   XP_750167   Lethal          4&#195;&#190;            4              4&#195;&#190;             4&#195;&#190;             ND i <br />                                                                       TIF35    Translation initiation factor eIF3                 XP_755320   Lethal          4&#195;&#190;            2              4&#195;&#190;             4&#195;&#190;             Slow cidal <br />                                          Protein transport            SEC31    Component COPII coat secretory pathway   XP_755629   Lethal          4&#195;&#190;            2              4&#195;&#190;             4&#195;&#190;             Cidal <br />                                                                                vesicles <br />                                                                       SEC62    Component endoplasmic reticulum protein-        XP_755590   Lethal          3&#195;&#190;            9              0&#195;&#190;             0&#195;&#190;             NDi <br />                                                                                translocation subcomplex <br />                                                                       SLY1     Protein involved vesicle trafficking            XP_754194   Lethal          4&#195;&#190;            2              4&#195;&#190;             4&#195;&#190;             Cidal <br />  <br />  <br />  <br />  <br /> March 2007 | Volume 3 | Issue 3 | e24 <br />                                                                                                                                                                                                                                         A. fumigatus Essential Gene <br />                                           Table 2. Continued. <br />  <br />                                          Biological Process          Gene             Gene Description S. cerevisiae                           GenBank           S. cerevisiae       C. albicans         Number            A. fumigatus         A. fumigatus        Cidal/Static <br />                                                                      Name                                                                         Accession         Null Mutant         Phenotypec          A. fumigatus         Phenotype            Phenotype           Phenotype <br />                                                                                                                                                   Numbera           Phenotypeb                              pNiiA-CPR            AMM &#195;&#190;             ACM &#195;&#190;e <br />                                                                                                                                                                                                             Mutants              Ammonium <br />                                                                                                                                                                                                             Recoveredd <br />  <br />                                                                      TIP20            Cytoplasmic protein required endoplasmic                XP_754506         Lethal              4&#195;&#190;                  2                    0&#195;&#190;                   0&#195;&#190;                  NDi <br />                                                                                       reticulum Golgi transport <br />  <br />  <br />  <br />  <br /> PLoS Pathogens | www.plospathogens.org <br />                                                                      TOM22            Core component general import complex                    XP_752552         Lethal              3&#195;&#190;                  2                    0&#195;&#190;                   0&#195;&#190;                  NDi <br />                                                                      TOM40            Mitochondrial import receptor subunit                       XP_747566         Lethal              4&#195;&#190;                  2                    4&#195;&#190;                   4&#195;&#190;                  NDi <br />                                          Ribosome biogenesis         BRX1             Protein required rRNA maturation                        XP_749971         Lethal              4&#195;&#190;                  2                    4&#195;&#190;                   4&#195;&#190;                  Static <br />                                                                      ESF1             Protein required 18S rRNA biogenesis                    XP_749672         Lethal              3.5                 2                    4&#195;&#190;                   4&#195;&#190;                  Static <br />                                                                      KRR1             Component 90S preribosomal particles                     XP_755471         Lethal              4&#195;&#190;                  4                    4&#195;&#190;                   4&#195;&#190;                  Cidal <br />                                                                      MAK5             Probable RNA-helicase DEAD box family                XP_750779         Lethal              3.5&#195;&#190;                2                    4&#195;&#190;                   4&#195;&#190;                  Slow cidal <br />                                                                      NOB1             Essential protein functions 20S                     XP_747944         Lethal              3&#195;&#190;                  3                    3.5&#195;&#190;                 3.5&#195;&#190;                Static <br />                                                                                       proteasome maturation 26S proteasome <br />                                                                                       assembly, component pre-40S ribosomal particle <br />                                                                      NOC3             Protein involved biogenesis 60S               XP_756039         Lethal              4&#195;&#190;                  4                    4&#195;&#190;                   4&#195;&#190;                  Static <br />  <br />  <br />  <br />  <br /> 0007 <br />                                                                                       ribosomal subunit <br />                                                                      NOP4             Nucleolar protein required ribosome                     XP_752199         Lethal              3&#195;&#190;                  3                    4&#195;&#190;                   4&#195;&#190;                  Static <br />                                                                                       biogenesis <br />                                                                      SSU72            Protein phosphatase                                         XP_749508         Lethal              3.5&#195;&#190;                2                    0&#195;&#190;                   0&#195;&#190;                  NDi <br />                                          RNA splicing                LUC7             U1 snRNA-associated protein                                 XP_750789         Lethal              4&#195;&#190;                  3                    4&#195;&#190;                   4&#195;&#190;                  Slow cidal <br />                                          Sporulation                 PRB1             Protease B                                                  XP_753718         Viable              3&#195;&#190;                  2                    0&#195;&#190;                   0&#195;&#190;                  NDi <br />                                          Unknown                     Orf19. 3901      Unknown                                                     XP_753124          l                  3&#195;&#190;                  2                    0&#195;&#190;                   0&#195;&#190;                  NDi <br />                                                                      Orf19. 9098      Unknown                                                     XP_752204          l                  3&#195;&#190;                  2                    0&#195;&#190;                   0&#195;&#190;                  NDi <br />  <br />  <br />                                          a <br />                                            Amino acid sequences retrieved GenBank (http://www.ncbi.nlm.nih.gov/Genbank/index.html), using specified accession numbers. <br />                                          b <br />                                             S. cerevisiae null mutant phenotypes annotated SGD (http://www.yeastgenome.org). <br />                                          c <br />                                            C. albicans phenotypes determined using tetracycline regulatable promoter [11] minimal medium (YNB). <br />                                          d <br />                                            In cases, independent pNiiA-CPR mutants recovered. <br />                                          e <br />                                            Phenotype scored ACM (Aspergillus-rich medium) containing ammonium. <br />                                          f <br />                                            These mutants display conditional essential phenotypes. <br />                                          g <br />                                            NA (not applicable): GRACE strains contain extraneous HIS3 gene integral tetracycline-regulatable promoter [11], rendering unsuitable evaluating endogenous HIS3 gene phenotype. <br />                                          h <br />                                            Underlined genes indicate A. fumigatus gene families. <br />                                          i <br />                                           ND (not determined): Cidal/static terminal phenotype determined using pNiiA-CPR mutants displaying 3.5&#195;&#190; 4&#195;&#190; shutoff growth defect. <br />                                          j <br />                                            The fks1Dfks2D double mutation lethal. <br />                                          k <br />                                            Null mutants lethal certain genetic backgrounds. <br />                                          l <br />                                           , No apparently homologous genes exist species. <br />                                          doi:10.1371/journal.ppat.0030024.t002 <br />  <br />  <br />  <br />  <br /> March 2007 | Volume 3 | Issue 3 | e24 <br />                                                                                                                                                                                                                                                                                          A. fumigatus Essential Gene <br />                                                                                                                         A. fumigatus Essential Gene <br />  <br />  <br />  <br />  <br /> Figure 4. Analysis pNiiA-CPR Associated Morphological Terminal Phenotypes <br /> Terminal growth phenotypes pNiiA-CPR mutants observed microscope (3160) conidia grown 36 40 h 30 8C under <br /> standard repressing conditions. A continuum conidia germination phenotypes high penetrance observed; ranging completely <br /> failing undergo polarized growth (SEC31, SLY1) swollen highly disorganized condidia (GFA1), displaying stunted (TUB1, ERG10) or <br /> nonbranching germlings swollen conidia (HEM15) rudimentary polarized growth. Micromycelial colonies observed pNiiA-FKS1 <br /> mutant resembling morphology wild-type A. fumigatus grown presence minimum effective concentration (MEC) FKS1p <br /> inhibitor, caspofungin [21]. Growth phenotypes inducing conditions shown Figure S3. <br /> doi:10.1371/journal.ppat.0030024.g004 <br />  <br />  <br /> known target azole-based antifungal agents) exist A.                   sing conditions (Figure 6, Table 1). Further, viable erg11AD <br /> fumigatus [22,23]. While disruption ERG11A displays                    erg11BD null mutants displaying robust growth were <br /> effect growth ergosterol levels [23], remained                      readily recovered (Figure 6, Table 1). Thus, data <br /> unknown ERG11B gene pair                       demonstrate member ERG11 gene family <br /> is essential A. fumigatus. To address this, individual pNiiA-             essential individually A. fumigatus. To examine whether <br /> CPR mutants ERG11A ERG11B constructed,                      ERG11 gene family essential, double mutant was <br /> neither producing noticeable growth defect repres-                   constructed creating pNiiA-ERG11A allele an <br />  <br />       PLoS Pathogens | www.plospathogens.org                          0008                                  March 2007 | Volume 3 | Issue 3 | e24 <br />                                                                                                                                 A. fumigatus Essential Gene <br />  <br />  <br />  <br />  <br /> Figure 5. Determination Cidal Static Terminal Phenotypes <br /> A representative example cidal static terminal phenotypes for <br /> GFA1 TRR1 pNiiA-CPR mutants shown. <br /> (A) pNiiA-GFA1 displayed cidal terminal phenotype dramatic <br /> (greater 90%) reduction CFU observed incubation in <br /> pNiiA-repressing conditions 24 48 h. <br /> (B) pNiiA-TRR1 revealed static terminal phenotype significant <br /> reduction CFU counts detected 48-h incubation under <br /> repressing conditions. A summary additional cidal/static terminal <br /> phenotypes A. fumigatus genes displaying 4&#195;&#190; qualitative growth <br /> phenotypes provided (see Table 2). <br /> doi:10.1371/journal.ppat.0030024.g005 <br />  <br />  <br />  <br />  <br />                                                                                   Figure 7. In Vivo Validation A. fumigatus pNiiA-CPR Mutants an <br />                                                                                   Immunocompromised Murine Model Systemic Infection <br />                                                                                   (A) pNiiA-CPR mutants growing AMM plus 20% mouse serum (Sigma) <br />                                                                                   reproduced terminal growth phenotypes observed either <br />                                                                                   AMM plus ammonium rich medium (Table 2). <br />                                                                                   (B C) In vivo validation pNiiA-CPR mutants. (B) ICR male mice were <br /> Figure 6. Phenotypic Analyses ERG11 Gene Family                                immunocompromised administration cyclophosphamide 150 <br />                                                                                   mg/kg twice prior infection 100 mg/kg twice week after <br /> Growth phenotypes ERG11 gene family observed pNiiA-CPR               infection. Approximately 105 viable conidia individual pNiiA-CPR <br /> mutants, null deletion mutants, double mutants (erg11BD, pNiiA-               mutants (TUB1, SEC31, GCD6, GFA1, MET2, AUR1) injected into <br /> ERG11A). Strains grown inducing medium (AMM plus                   tail vein immunocompromised mice (five mice group). Signs of <br /> nitrate) repressing medium (AMM plus ammonium) 30 8C 40 h.              infection monitored 12 d following infection. Wild-type <br /> doi:10.1371/journal.ppat.0030024.g006                                             strain CEA10 starting strain CEA17 (a pyrG  auxotroph CEA10) <br />                                                                                   [25,39] included positive controls virulence avirulence, <br /> ERG11B null mutant background (see Materials Meth-                            respectively. <br />                                                                                   (C) Genetic inactivation ERG11 gene family promotes avirulence in <br /> ods). The resulting ERG11 double mutant (erg11BD, pNiiA-                          immunocompromised murine model systemic infection. Patho- <br /> ERG11A) displays robust growth inducing con-                            genesis erg11AD, erg11BD, ERG11 double mutant (erg11BD, <br /> dition, growth evident repressing conditions                        pNiiA-ERG11A) similarly analyzed (as described above) a <br />                                                                                   longer postinfection period (22 d), animal <span id='am-3' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-4' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-5' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-7' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-14' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-48' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span>survival</span> compared to <br /> (Figure 6). Therefore, data suggest                      CEA10 CEA17 control strains. <br /> ERG11 gene pair functionally compensate loss                       doi:10.1371/journal.ppat.0030024.g007 <br /> other, genetic inactivation ERG11A and <br /> ERG11B indicates essentiality A. fumigatus. <br />                                                                                   serum (Figure 7A). In case, TUB1, SEC31, GCD6, GFA1, <br /> In Vivo Analysis pNiiA-CPR Mutants Murine Model                           MET2, AUR1, pNiiA-ERG11A, erg11BD CPR mutants <br /> of Systemic Aspergillosis                                                         reproduced terminal growth phenotypes observed <br />   Animal models fungal pathogenesis provide important                          AMM rich medium (Table 2), demonstrating that <br /> experimental veri&#239;&#172;?cation genetic mutations abro-                          mouse serum levels ammonium (or primary nitrogen <br /> gate (or attenuate) virulence pathogen. As mouse                       source) suf&#239;&#172;?cient repress NiiA promoter. Indeed, as <br /> serum contains approximately 200 lM ammonium [24]                             higher ammonium levels (approximately 1 4 mM) of <br /> such levels ammonium theoretically suf&#239;&#172;?cient                            repressor exist mouse tissues (e.g., liver, kidney, brain, <br /> repress pNiiA promoter, tested streaking                           muscle) [24], reasoned virulence pNiiA-CPR <br /> pNiiA-CPR mutants AMM plates containing 20% mouse                            mutants examined murine model aspergil- <br />  <br />       PLoS Pathogens | www.plospathogens.org                               0009                                     March 2007 | Volume 3 | Issue 3 | e24 <br />                                                                                                                                  A. fumigatus Essential Gene <br />  <br />  <br /> losis. To test this, animal model &#239;&#172;?rst established using <br /> mice immunocompromised cyclophosphamide                        Table 3. MIC Antifungal Drugs pNiiA-CPR Strains <br /> and infected 100,000 conidia tail vein injection (see <br /> Materials Methods). Control experiments demonstrate                     A. fumigatus Strain           Fluconazolea        Itraconazole       Tunicamycin <br /> that mice (n &#194;&#188; 5) infected wild-type virulent strain, <br /> CEA10, died infection 8 d, 100% survival                  pNiiA-ERG11A, induced         .100                0.6                .128 <br />                                                                             pNiiA-ERG11A, repressedb      6.25 12.5        0.037 0.075     .128 <br /> was observed mice (n &#194;&#188; 5) infected known avirulent <br />                                                                             pNiiA-ERG11B, induced         .100                0.6                .128 <br /> strain, CEA17 [25]. Virulence CPR mutants TUB1,                       pNiiA-ERG11B, repressed       .100                0.6                .128 <br /> SEC31, GCD6, GFA1, AUR1, MET2 similarly examined                    erg11AD                       6.25 12.5        0.037 0.075     .128 <br /> (Figure 7B). No mortality morbidity observed mice                erg11BD                       .100                0.6                .128 <br /> infected pNiiA-TUB1 12-d period, predicted                 pNiiA-ALR1, induced           .100                0.6                .128 <br />                                                                             pNiiA-ALR1, repressed         .100                0.6                .128 <br /> for core essential gene signi&#239;&#172;?cantly repressed            pNiiA-ALG7, induced           .100                0.6                .128 <br /> which suf&#239;&#172;?cient vivo ammonium levels exist. Similarly,                   pNiiA-ALG7, repressedc        .100                0.6                8.0 16.0 <br /> pNiiA-based repression suf&#239;&#172;?cient fully abrogate                      pNiiA-SPE2, induced           .100                0.6                .128 <br /> virulence SEC31, GFA1, GCD6 (Figure 7B). Further,                    pNiiA-SPE2, repressed         .100                0.6                .128 <br />                                                                             CEA10 (wild-type)             .100                0.6                .128 <br /> whereas erg11AD erg11BD mutants similarly <br /> virulent wild-type CEA10, ERG11 double mutant <br />                                                                             a <br /> (erg11BD, pNiiA-ERG11A) fully avirulent extended                  All MIC values given lg/ml. <br />                                                                             b <br />                                                                               To repress ERG11A, ERG11B, ALR1 pNiiA-CPR mutants, strains assayed AMM <br /> 22-d period (Figure 7C). On hand, attempted                       containing 10 mM ammonium. <br /> repression MET2 AUR1 effect A. fumigatus                   c <br />                                                                              To repress ALG7 SPE2 pNiiA-CPR mutants, strains assayed AMM containing 5 <br /> virulence (Figure 7B). As pNiiA-MET2 growth unaffected                  mM ammonium 5 mM nitrate. <br />                                                                             doi:10.1371/journal.ppat.0030024.t003 <br /> by serum, C. albicans MET2 tetracycline-regulatable <br /> conditional mutant similarly virulent [10], likely <br /> re&#239;&#172;&#8218;ects suf&#239;&#172;?cient levels methionine scavenged                &#239;&#172;&#8218;uconazole. Indeed, pNiiA-ERG11A mutant displayed <br /> support growth vitro vivo. Although                      8- 16-fold lower MIC &#239;&#172;&#8218;uconazole; detectable drug <br /> observed virulence phenotype pNiiA-AUR1 remains                          hypersensitivity observed pNiiA-ERG11B or <br /> unclear (see Discussion), demonstrate pNiiA-CPR                     control strains tested (Table 3). MIC determinations using <br /> mutants generally gave vivo phenotypes consistent                   null mutants erg11AD erg11BD independently con- <br /> reliable repression achieved.                                         &#239;&#172;?rmed depletion ERG11A (rather ERG11B) <br />                                                                             similarly sensitizes A. fumigatus 8- 16-fold &#239;&#172;&#8218;uconazole. <br /> Chemical Hypersensitivity pNiiA-CPR Mutants                              Moreover, depletion ERG11A, pNiiA-CPR <br />    In principle, partially depleting activity particular           mutant null mutant, produced hypersensitivity itraco- <br /> gene product sensitizes cells compounds act                 nazole, triazole that, unlike &#239;&#172;&#8218;uconazole, displays <br /> that target. Modulating gene dosage achieved                      strong activity wild-type A. fumigatus (Table 3). Neither <br /> deleting copy diploid organism [6,26], antisense                   pNiiA-CPR mutants null mutants ERG11A ERG11B <br /> interference [8], reduced gene expression titrat-                displayed change MIC tunicamycin. This preferential <br /> able repression regulatable promoter [11]. To test                     drug sensitivity mutants depleted A. fumigatus ERG11A <br /> whether intermediate expression levels pNiiA-CPR mu-                     supports feasibility target-based sensitized <br /> tants achieved produce chemical hypersensitivity,               cell assays using pNiiA-CPR mutants. These data also <br /> we &#239;&#172;?rst examined chemical sensitivity pNiiA-ALG7                   suggest ERG11A likely encodes major 14a-demethylase <br /> mutant cognate inhibitor, tunicamycin. A partial                     activity ERG11A, ERG11B, largely <br /> depletion Alg7p inferred growing pNiiA-ALG7                    contributes poor susceptibility A. fumigatus to <br /> the presence ammonium/nitrate ratio suf&#239;&#172;?cient                      &#239;&#172;&#8218;uconazole (see Discussion). <br /> reduce growth rate approximately 50%. Under such <br /> conditions, depletion Alg7p resulted 8- 16-fold                 Discussion <br /> shift minimum inhibitory concentrations (MICs) to <br /> tunicamycin signi&#239;&#172;?cant change sensitivity                    In report, pNiiA-CPR strategy to <br /> either &#239;&#172;&#8218;uconazole itraconazole (Table 3). Moreover,                   construct A. fumigatus conditional mutants directly <br /> signi&#239;&#172;?cant change tunicamycin MIC observed                  identify evaluate gene essentiality vitro vivo. <br /> panel similarly sensitized pNiiA-CPR mutants (Table 3).                  Replacement endogenous gene promoter pNiiA <br /> Therefore, partial depletion A. fumigatus Alg7p resulted             typically enables robust shutoff gene expression assess <br /> in speci&#239;&#172;?c hypersensitivity tunicamycin.                               terminal growth phenotypes including intracellular, morpho- <br />    A. fumigatus exhibits extremely low susceptibility                 logical, cidal growth consequences. Collectively, the <br /> &#239;&#172;&#8218;uconazole (MIC . 256 lg/ml), feature attributed                   completion A. fumigatus genomic sequence, under- <br /> genetic redundancy ERG11 pathogen [22,23]. Using                 standing essential genes yeasts, pNiiA-CPR <br /> the conditional mutants, tested inactivation                  strategy enable rational approach determine the <br /> either member ERG11 gene family sensitize A.                     essentiality orthologous genes A. fumigatus. Indeed, <br /> fumigatus ERG11-speci&#239;&#172;?c inhibitors (Table 3). As                 genomic comparisons A. fumigatus other <br /> ERG11 gene displays growth defects repressing                    eukaryotes reveals that, 131 largely essential <br /> conditions, pNiiA-CPR mutants ERG11A ERG11B serve                    eukaryote orthologous groups, A. fumigatus ortholog is <br /> as cell assays growing mutant                      identi&#239;&#172;?ed [27]. Here demonstrate 73% the <br /> repressing conditions determining respective MIC                  predicted essential genes examined essential for <br />  <br />       PLoS Pathogens | www.plospathogens.org                         0010                                          March 2007 | Volume 3 | Issue 3 | e24 <br />                                                                                                                    A. fumigatus Essential Gene <br />  <br />  <br /> growth. Hence, broad spectrum antifungal targets                     disruption (Table 1). As ERG27 de&#239;&#172;?nes &#226;&#8364;&#732;&#226;&#8364;&#732;essential&#226;&#8364;&#8482;&#226;&#8364;&#8482; <br /> conserved major human fungal pathogens                         step S. cerevisiae ergosterol biosynthetic pathway and <br /> ef&#239;&#172;?ciently identi&#239;&#172;?ed. We demonstrate approach               ergosterol intermediates accumulate ERG mutants are <br /> can extended gene families (e.g., ERG11)               implicated causing phenotypes/chemotypes resulting <br /> resulting pNiiA-CPR mutants serve target-based cell              disrupting speci&#239;&#172;?c steps pathway [28], one <br /> assays suitable drug screening.                                       possibility presumed ergosterol intermediate <br />    To evaluate utility NiiA conditional promoter           (possibly 4-methylzymosterol 4,4-dimethylzymosterol) is <br /> studying gene essentiality, extensive analysis                  deleterious A. fumigatus growth. Indeed, extended <br /> regulatable expression performed. First, reliability              pNiiA-CPR analysis ergosterol pathway reveals that <br /> was examined genetic means. Conditional mutants                     additional genes de&#239;&#172;?ning essential steps this <br /> multiple genes encoding functions involved amino acid                  pathway S. cerevisiae (e.g., ERG26) essential A. <br /> biosynthesis constructed, showed 4&#195;&#190; shutoff                  fumigatus (W. Hu, H. Wang, S. Sillaots, S. Kauffman, J. Becker, <br /> growth phenotypes reversed adding                   et al., unpublished data). Other interesting examples include <br /> appropriate amino acids medium (Figure 2A, Table 2).               GDP-GTP exchange factors (GEF) ROM2 CDC24 that <br /> In addition, A. fumigatus genes examined pNiiA-CPR                 regulate Rho1p Cdc42p, respectively, S. cerevisiae <br /> strategy independently examined parasexual                       [29,30]. Again, ROM2 independently con&#239;&#172;?rmed as <br /> genetics strategy [12,13] yielded reproducible essential                  nonessential A. fumigatus viable knockout strain was <br /> growth phenotypes (Figure 2B). pNiiA-CPR mutants genes                 constructed (Table 1) despite lacking second clear homolog <br /> in melanin biosynthetic pathway gave predicted               A. fumigatus sharing high homology (1e-155) an <br /> terminal conidia color change characteristic known               essential C. albicans ortholog. In contrast, A. fumigatus gene <br /> null phenotype (Figure 2C) [19]. Thus, genetic data strongly              identi&#239;&#172;?ed sharing greatest homology CDC24 lacks <br /> suggest suf&#239;&#172;?ciently achievable repression levels                 striking homology (7e-30) S. cerevisiae C. albicans CDC24 <br /> obtained pNiiA promoter independent gene                    functionally distinct CDC24. Regard- <br /> to linked physical location                 less, unexpected GEF proteins critical the <br /> genome. We directly compared terminal phenotypes                  process polarized growth yeast nonessential <br /> A. fumigatus nudC genes achieved pNiiA-CPR strategy                 absent A. fumigatus mycelial growth process, is <br /> that achieved alcA conditional promoter [15]                similarly case multiple polarized growth positional <br /> and obtained highly comparable nudC terminal phenotypes                   markers (e.g., BUD3, BUD8, BUD9) [27]. Indeed, these <br /> resembling reported null phenotype (Figures 2D S1).               examples stress requirement performing analyses <br /> Finally, comparative analysis performed terminal                 directly A. fumigatus. <br /> phenotypes seven genes evaluated pNiiA-CPR                   Our genetic analysis A. fumigatus ERG11 gene family <br /> gene disruption strategies. By methods, genes                  begins address relative role ERG11 gene <br /> (LUC7, TOM40, MET2) shown essential,                 member mycelial growth, issues relating to <br /> four genes (ERG11A, ERG11B, ERG27, ROM2)                   differences A. fumigatus activity azole-based drugs. <br /> to nonessential (Table 1).                                             We demonstrate genetic inactivation homolog <br />    Genetic interrogation pNiiA-CPR strategy supports             enzyme compensate lack other <br /> general reliability method, quantitative metrics          inactivation ERG11A ERG11B inviable <br /> expression levels achieved NiiA promoter                 A. fumigatus. Therefore, azole-based antifungal drugs must <br /> required. Multiple genes monitored RT-PCR displayed                    inhibit members ERG11 gene family order to <br /> repression levels noticeably wild-type expression levels            display potent inhibitory activity A. fumigatus. This <br /> (Figure 3A; Figure S2). Further, real-time RT-PCR                (in part) re&#239;&#172;&#8218;ect highly variable A. fumigatus MIC levels <br /> analysis expression levels pNiiA-CPR mutants                 azole-based drugs. In addition, demonstrate that <br /> ALR1, MET2, TUB1 demonstrates achievable repression                   ERG11A mutants (rather ERG11B mutants) specif- <br /> levels range approximately 16- 76-fold wild-           ically hypersensitive &#239;&#172;&#8218;uconazole, suggesting ERG11A <br /> type (Figure 3C 3D). In cases, overexpression             encodes major 14a-demethylase activity contributing to <br /> detected RT-PCR and/or real-time RT-PCR induc-                   poor susceptibility A. fumigatus drug. As ERG11A <br /> ing conditions. Although deleterious growth consequences               mutant displays hypersensitivity itraconazole and <br /> were observed, intrinsic overexpression complicate                    additional azoles [23], ERG11A encode major 14a- <br /> pNiiA-CPR mutant construction and/or analysis                     demethylase activity required mycelial growth. Consistent <br /> instances.                                                                view, multiple missense mutations ERG11A <br />    Despite high concordance A. fumigatus gene essentiality           (rather ERG11B) linked itraconazole and <br /> to known essential S. cerevisiae C. albicans orthologs,               posoconazole resistance UV mutagenesis studies and <br /> several exceptions observed. In instances,              analysis azole-resistant clinical isolates A. fumigatus <br /> due gene redundancy, demonstrated                    [31&#226;&#8364;&#8220;33]. ERG11Ap possess inherently greater <br /> genetic analysis ERG11 gene family similarly               resistance azoles, biochemical studies are <br /> relate ALR1. However, nonessential phenotypes                    required address possibility. Additional studies are <br /> determined gene set surprising. For                    required address functional role ERG11B. <br /> example, ERG27, essential S. cerevisiae C.           Although demonstrate solely required A. <br /> albicans, lacked clear growth phenotype A. fumigatus. This           fumigatus pathogenesis, unclear ERG11B serves <br /> phenotype attributed failure pNiiA                exclusively redundant role ERG11A more <br /> promoter suf&#239;&#172;?ciently repress ERG27 expression                 specialized function particular conditions. <br /> could construct viable ERG27 deletion mutant gene                       A variety alternative strategies (see Introduction) to <br />  <br />       PLoS Pathogens | www.plospathogens.org                       0011                                 March 2007 | Volume 3 | Issue 3 | e24 <br />                                                                                                                     A. fumigatus Essential Gene <br />  <br />  <br /> genetically investigate gene function A. fumigatus                  differential level repression achieved versus wild-type <br /> currently pursued, possible,                       expression qualitative level expression <br /> compared pNiiA-CPR terminal phenotypes reported                   necessary support function, vary between <br /> [12&#226;&#8364;&#8220;15]. Recently, doxycycline-regulated gene expression                 genes predicted. For example, rule <br /> system A. fumigatus reported, remains             possibility observed pNiiA-AUR1 virulence <br /> tested using endogenous A. fumigatus gene [16]. Unlike                  (despite gene displaying 4&#195;&#190; growth phenotype) may <br /> previous reports, work employs directed strategy                  re&#239;&#172;&#8218;ect insuf&#239;&#172;?cient shutoff host. Alternatively, <br /> systematically evaluate A. fumigatus essential genes                  pNiiA-AUR1 mutant suppressed vivo the <br /> relatively large scale distinguish cidal static             uptake host sphingolipids manner analogous that <br /> growth-arrested terminal phenotypes. Importantly, regu-                reported Candida glabrata ERG11 ERG9 mutants (see <br /> latable promoter approach circumvents need comple-                  below) [37,38]. Notwithstanding limitation, multiple (n &#194;&#188; <br /> ment mutants corresponding wild-type gene;                    5) individual pNiiA-CPR mutants unambiguously be <br /> dif&#239;&#172;?cult time-consuming process A. fumigatus. The                   con&#239;&#172;?rmed avirulent murine model, strongly <br /> ability recover multiple, independently generated, pro-                 suggesting general utility (Figure 7B 7C). Indeed, <br /> moter replacement mutants method serves                    potential drug targets missed, are <br /> reinforce gene-speci&#239;&#172;?c phenotypes observed. Unlike                     de&#239;&#172;?nitively identi&#239;&#172;?ed, GFA1, directly <br /> alternative strategies, demonstrate pNiiA-CPR mu-                  con&#239;&#172;?rmed (1) essential growth, (2) displaying cidal <br /> tants used validate gene essentiality                  terminal phenotype, (3) avirulent murine model of <br /> immunocompromised murine model infection. Patho-                        pathogenesis. Although murine model does re&#239;&#172;&#8218;ect a <br /> genesis studies assist prioritization essential genes drug          true pulmonary aspergillosis infection model (because mice <br /> screening provide genetic prediction cognate                    infected tail vein injection the <br /> inhibitors display similar ef&#239;&#172;?cacy animal model                normal route infection, inhalation), improve- <br /> of infection. Finally, unlike genetic screen, approach              ments envisioned. Also, unlike tetracycline- <br /> allows up-front systematic examination speci&#239;&#172;?c A.                    regulatable promoter [11], virulence pNiiA-CPR <br /> fumigatus genes meet bioinformatic spectrum criteria                  mutants evaluated perspective of <br /> and/or essential phenotypes fungal organisms and, <br />                                                                            prophylactic antifungal drug targets repression is <br /> hence, enables rapid focused survey potential broad- <br />                                                                            constitutive controlled. Nonetheless, pNiiA-CPR <br /> spectrum antifungal drug targets. In way, demonstrate <br />                                                                            mutants provide unique advantage alternative meth- <br /> a signi&#239;&#172;?cant enrichment identi&#239;&#172;?cation validation <br />                                                                            ods [12,13,15] validate A. fumigatus genes pathogenesis <br /> of essential genes pathogen envision utility <br />                                                                            studies. <br /> could expanded. <br />                                                                               Formal demonstration gene essentiality con&#239;&#172;?rmed in <br />    The principal limitation pNiiA-CPR strategy that, <br />                                                                            vitro confers avirulent phenotype necessary, as <br /> as promoter replacement strategy, fail to <br />                                                                            exempli&#239;&#172;?ed phenotypic analysis ERG11 fungal <br /> correctly identify gene essentiality cases endogenous <br />                                                                            pathogens. Surprisingly, ERG11 ERG9 essential <br /> gene expression levels naturally lower residual <br />                                                                            murine model C. glabrata infection, despite genes <br /> level achieved repression NiiA promoter. Although <br />                                                                            con&#239;&#172;?rmed essential vitro [37,38]. Instead, C. <br /> our data demonstrate limitations common, <br /> we rule complication predict                  glabrata ERG11 ERG9 mutants virulent host <br /> occurrence individual genes tested. In cases                 environment, demonstrated scavenge host <br /> more rigorous analysis single (or relatively small number             cholesterol suppress ergosterol biosynthetic defects [37,38]. <br /> of genes) particular interest, independent veri&#239;&#172;?cation            Direct experimentation required rule this <br /> of null phenotype(s) performed gene                       phenotype extends A. fumigatus. Although ERG11A <br /> disruption, performed Table 1. An advantage                  ERG11B mutants avirulent, ERG11 double <br /> approach pNiiA-CPR strategy offers means                  mutant (erg11BD, pNiiA-ERG11A) completely avirulent. In <br /> identify majority essential genes pathogen.                 case novel antifungal targets, predict <br /> Minor technical limitations approach relate                 consequences inactivation animal model <br /> requirement predict gene&#226;&#8364;&#8482;s correct start codon,               neglect direct experimental con&#239;&#172;?rmation. More- <br /> can particularly dif&#239;&#172;?cult A. fumigatus genes             over, A. fumigatus pathogenesis likely re&#239;&#172;&#8218;ects saprophytic <br /> contain extremely short 59 exons. In addition, construction             lifestyle virulence factors remain identi&#239;&#172;?ed, a <br /> pNiiA-CPR cassettes involves step-by-step subcloning                    pNiiA-CPR strategy demonstrating avirulence essential <br /> introduce suf&#239;&#172;?cient &#239;&#172;&#8218;anking homology given gene.                   genes offers broad set potential drug targets. <br /> Greater throughput cassette constructions                         In conclusion, pNiiA-CPR strategy overcomes number <br /> achieved using gap repair methods amenable S. cerevisiae                historical challenges applying molecular genetics A. <br /> [34]. Although relatively large regions &#239;&#172;&#8218;anking homology                fumigatus highly amenable genetically investigate A. <br /> are required correctly target promoter replacement                      fumigatus biology validate essential genes this <br /> cassettes, shorter &#239;&#172;&#8218;anking regions used con-                   important human fungal pathogen. This approach facilitates <br /> junction recipient strain deleted Ku70 Ku80                   phenotypic analysis vitro vivo, the <br /> [35,36].                                                                   resulting conditional mutants serve target-based cell <br />    Limitations murine model described exist.                   assays, enabling discovery, prioritization, and <br /> Again, residual levels expression pNiiA-CPR mutants               screening novel antifungal targets directly A. fumigatus. <br /> vivo suf&#239;&#172;?cient produce avirulent                   Indeed, promoter replacement strategies C. albicans [11] <br /> phenotype. This depends quantitatively                     A. fumigatus encourage broader application. <br />  <br />       PLoS Pathogens | www.plospathogens.org                        0012                                 March 2007 | Volume 3 | Issue 3 | e24 <br />                                                                                                                                  A. fumigatus Essential Gene <br />  <br />  <br /> Materials Methods                                                              mutants failed grow repressed media (AMM plus <br />                                                                                    ammonium). Other growth phenotypes scored 3.5&#195;&#190; (very <br />    Strains, media, cultural conditions. A. fumigatus wild-type strain          strong), 3&#195;&#190; (strong), 2&#195;&#190; (mild), 1&#195;&#190; (minor), 0&#195;&#190; (no growth <br /> CEA10 uracil uridine auxotroph, CEA17, used               phenotype) (Figure 1C). <br /> study [39]. ACM AMM prepared reported [40]. ACM                           Cidal/static phenotypic analysis. To determine terminal cidal/ <br /> supplemented uracil uridine used obtain CEA17                      static phenotypes A. fumigatus essential genes, 1 3 103 1 3 104 <br /> conidia suspensions produce mycelia protoplast prepara-                 conidiospores incubated broth AMM plus 10 mM ammonium <br /> tion. For protoplast transformation, modi&#239;&#172;?ed AMM used                   tartrate (repressing condition) 0 (time zero control), 24, 48, 72 <br /> contained 10 mM Mg(NO3)2 sole nitrogen source 1% (w/v)                  h; washed PBS twice; plated inducing media plate <br /> glucose sole carbon source (AMM plus nitrate). In addition,                 (AMM plus 10 mM nitrate) CFU counting. A cidal phenotype was <br /> AMM (AMM plus ammonium) contained 10 mM ammonium                              assigned genes conditional mutant displayed a <br /> tartrate (C4H12N2O6; Sigma, http://www.sigmaaldrich.com) sole               signi&#239;&#172;?cant CFU reduction (greater 90%) 24 h under <br /> nitrogen source used repress pNiiA phenotypic analysis              repressing conditions. Slow cidal targets displayed <br /> of pNiiA-CPR mutant. A. fumigatus grown 37 8C                  reduced cell viability 48 72 h, respectively. <br /> otherwise mentioned.                                                                  Immunocompromised murine model systemic infection. A. <br />    Construction plasmid pPyrG-pNiiA. Plasmid pPyrG-pNiiA                    fumigatus strains tested virulence immunocompromised <br /> constructed follows (Figure 1A). Brie&#239;&#172;&#8218;y, A. niger pyrG selectable           murine model systemic infection using CD-1 male mice (22 25 <br /> marker pNiiA sequence ampli&#239;&#172;?ed PCR plasmid                    g; Charles River Laboratories, http://www.criver.com). Mice were <br /> pAB4-ARp [41] (kindly provided Christophe d&#226;&#8364;&#8482;Enfert, Institut                    housed &#239;&#172;?ve cage food water supplied ad libitum. All <br /> Pasteur), A. fumigatus genomic DNA, respectively, using gene-                  experiments performed according National Institutes of <br /> speci&#239;&#172;?c primers containing multiple cloning sites (Table S1). The                  Health guidelines ethical treatment animals. Mice were <br /> above PCR products pyrG pNiiA &#239;&#172;?rst digested Not1/                 rendered immunocompromised treatment cyclophospha- <br /> Nde1 Nde1/Xho1, respectively, subcloned pBlue-                   mide 150 mg/kg 4 d 1 d prior infection 100 mg/kg twice <br /> script (SK; Stratagene, http://www.stratagene.com) Not1/Xho1                week infection. A. fumigatus conidial suspensions were <br /> sites. The resulting plasmid pPyrG-pNiiA, contains pyrG-                  prepared 4- 5-d-old cultures grown solid medium by <br /> pNiiA cassette &#239;&#172;&#8218;anked couple cloning sites                harvesting conidia gentle shaking hand using 5 ml PBS, <br /> (Figure 1A).                                                                       0.2% Tween-20, 3 ml glass beads. The conidial suspension was <br />    Construction pNiiA-CPR cassette. Through subcloning                        centrifuged (3,000g, 5 min), pellet resuspended 0.01% <br /> strategy, CPR cassette constructed included A. niger PyrG             Tween-20, conidia counted hemacytometer. <br /> selectable marker pNiiA sequence &#239;&#172;&#8218;anked                Immunocompromised mice infected tail vein injection 0.1 <br /> approximately 1.5 kb gene-speci&#239;&#172;?c &#239;&#172;&#8218;anking sequence (Figure 1B).                 ml conidial suspension 1 3 106 conidia/ml. After injection, the <br /> Brie&#239;&#172;&#8218;y, CPR cassette constructed steps. In step 1,                  conidia suspensions diluted plated determine viable <br /> approximately 1.5-kb 59-&#239;&#172;&#8218;anking sequence (left arm) usually               count inoculum. Mice monitored times daily for <br /> 250 bp upstream ATG start codon target gene                      signs infection, 12 22 d. Animals considered <br /> ampli&#239;&#172;?ed PCR A. fumigatus CEA10 genomic DNA                       moribund longer reach food water. Moribund <br /> gene-speci&#239;&#172;?c primers subcloned suitable cloning sites                mice, surviving end experiment, were <br /> (usually Not1 Mlu1) pyrG plasmid pPyrG-pNiiA.                killed anesthetization followed cervical dislocation. All tested <br /> In step 2, approximately 1.5-kb downstream (39-) genomic &#239;&#172;&#8218;anking                   CPR mutants coded laboratory workers did know the <br /> sequence (right arm) starts ATG start codon ampli&#239;&#172;?ed               identity strains. For strain, &#239;&#172;?ve mice infected. <br /> <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> A. fumigatus CEA10 genomic DNA gene-speci&#239;&#172;?c                             Essential gene validation ORF disruption. To disrupt the <br /> primers subcloned pNiiA plasmid pPyrG-                   complete ORF target gene, disruption cassette constructed. <br /> pNiiA (usually Asc1 Pac1 sites). The resulting pNiiA-CPR                    Brie&#239;&#172;&#8218;y, 59-&#239;&#172;&#8218;anking sequence (approximately 1.5 kb, upstream the <br /> cassette excised plasmid digesting restriction                ATG start codon) target gene ampli&#239;&#172;?ed PCR using two <br /> enzymes end cassette (usually Not1 Pac1)                  gene-speci&#239;&#172;?c primers subcloned Not1/Mlu1 sites of <br /> used transform A. fumigatus strain CEA17 (see below).                           plasmid pPyrG-pNiiA (Figure 1A). Similarly, 39-&#239;&#172;&#8218;anking sequence <br />    Protoplast preparation transformation. Promoter replacement                 (approximately 1.5 kb, downstream stop codon) ampli&#239;&#172;?ed <br /> cassette (pNiiA-CPR cassette) DNA introduced A. fumigatus                 PCR subsequently subcloned Nde1/Pac sites of <br /> strain CEA17 (pyrG ) protoplast transformation according                     plasmid pPyrG-pNiiA. The resulting plasmid digested using Not1/ <br /> established procedures minor modi&#239;&#172;?cations [42]. Brie&#239;&#172;&#8218;y,                       Pac1 introduced CEA17 strain protoplast trans- <br /> protoplasts prepared freshly grown mycelium using lysing                 formation (see above). Transformants incubated ACM <br /> enzyme (Sigma) (0.5 g 50 ml digestion). From 5 10 lg excised             uracil uridine subjected genotypic analysis <br /> CPR-cassette DNA used transformation,                         PCR using primer sets verify disruption junctions ORF <br /> transformants grown 37 8C 3 d AMM (AMM plus 10                      disruption. Gene essentiality inferred genotype-con&#239;&#172;?rmed <br /> mM nitrate) containing 1.2 M sorbitol osmotic stabilizer                    transformants recovered large population of <br /> lacking uridine uracil. Three days post-transformation, trans-                 transformants (n . 80). Otherwise, genotype-con&#239;&#172;?rmed trans- <br /> formants transferred fresh AMM plus nitrate plates                formants recovered, target gene de&#239;&#172;?ned nonessential. <br /> subjected genotypic phenotypic analysis.                                       ERG11 double knockout. To validate gene essentiality the <br />    Genotypic analysis. A PCR strategy used con&#239;&#172;?rm double-                   ERG11A/ERG11B gene family, double knockout mutant was <br /> crossover integrated promoter replacements mutants                 constructed follows. In step 1, ERG11B null mutant (erg11BD) <br /> endogenous promoter target gene precisely replaced                 constructed disruption ERG11B ORF using a <br /> with pNiiA (Figure 1B). Genomic DNA prepared using DNeasy                  pyrG-based gene disruption cassette described above. In step 2, the <br /> plant kit (Qiagen, http://www.qiagen.com) transformants grown                 pyrG selection marker recycled erg11BD facilitate the <br /> on AMM plus nitrate subjected genotypic analysis                    promoter replacement ERG11A. To achieve this, ERG11B gene <br /> PCR. Three PCRs performed, mapped                            disruption plasmid digested Mlu1 Asc1 remove the <br /> promoter replacement junctions using sets primers (L1                    PyrG-pNiiA insert cassette religated (Mlu1 Asc1 <br /> and L2 left-arm junction, R1 R2 right-arm junction),              provide compatible 59 overhangs) prior subsequent transformation <br /> the PCR using primer set L1/P con&#239;&#172;?rm presence                  Escherichia coli. The resulting plasmid puri&#239;&#172;?ed and <br /> endogenous promoter wild-type CEA10 PR mutants                   digested Not1 Pac1 excise ERG11B insert (comprising <br /> (Figure 1B). pNiiA-CPR mutants con&#239;&#172;?rmed                          fused 59 39 &#239;&#172;&#8218;anking sequences intervening pyrG-pNiiA <br /> genotypic analysis subjected monoconidial puri&#239;&#172;?cation,                 insert) used transform erg11BD. Transformants grown at <br /> the resulting monoconidial isolates recon&#239;&#172;?rmed PCR                      30 8C 48 h ACM containing 5 mM uridine uricine, <br /> described above.                                                                   respectively. The conidiospores resulting transformants were <br />    Phenotypic analysis CPR mutants. The phenotypes CPR                   collected plated AMM plates containing 10 mM <br /> mutants evaluated comparing growth phenotype                        nitrate 1 mg/ml 5-FOA counterselect pyrG  strains. The <br /> inducing (AMM plus 10 mM nitrate) repressing (AMM plus 10                      resulting pyrG  strain genotyped PCR con&#239;&#172;?rm the <br /> mM ammonium) conditions. Typically, terminal growth pheno-                     pyrG  selectable marker removed erg11BD. In step 3, <br /> type observed 36 40 h 30 8C streaking conidiospores             resulting pyrG , erg11BD strain used starting strain <br /> onto inducing repressing media. Qualitative scores assigned               perform promoter replacement ERG11A described above. <br /> to CPR mutants classify severity terminal                   Construction TUB1 tandem duplicate mutant. To construct <br /> growth phenotype observed. A 4&#195;&#190; phenotype assigned CPR                      TUB1 tandem duplicate mutants, TUB1 ORF plus approximately 1 kb <br />  <br />        PLoS Pathogens | www.plospathogens.org                               0013                                     March 2007 | Volume 3 | Issue 3 | e24 <br />                                                                                                                                             A. fumigatus Essential Gene <br />  <br /> of DNA sequence directly downstream stop codon                            typically failed germinate (greater 70%) minority (less <br /> ampli&#239;&#172;?ed PCR subcloned Asc1 Pac1 sites                       30%) formed short growth-arrested germ tubes incubated <br /> plasmid pPyrG-pNiiA (Figure 1A). The resulting plasmid used                       repressing conditions (16 h 30 8C). <br /> transform A. fumigatus CEA17 protoplast transformation                             (C D) Higher magni&#239;&#172;?cation (3400) phase contrast microscopy <br /> described above. Transformants incubated AMM plus nitrate                        DAPI staining pNiiA-nudC mutant incubated same <br /> without uracil uridine subjected genotypic analysis                      conditions above. <br /> by PCR using primer sets verify single crossover event.                               (E F) DAPI staining demonstrates nuclear distribution <br />    RT-PCR real-time RT-PCR. To perform RT-PCR, pNiiA-CPR                             phenotype pNiiA-nudC mutant multiple nuclei remain <br /> mutants wild-type grown AMM plus nitrate                              inside ungerminated conidia short growth-arrested germ <br /> (inducing) AMM plus ammonium (repressing) 37 8C 20 h.                       tubes repressing conditions (F) mycelia under <br /> Total RNA extracted using RNeasy plant mini kit (Qiagen)                         inducing conditions (E). <br /> according manufacturer&#226;&#8364;&#8482;s instructions. Total RNA samples <br /> were treated Turbo-DNase I 37 8C 30 40 min according                      Found doi:10.1371/journal.ppat.0030024.sg001 (5.3 MB PPT). <br /> to manufacturer&#226;&#8364;&#8482;s manual (Ambion, http://www.ambion.com).                            Figure S2. RT-PCR Analysis Expression Level Multiple pNiiA- <br /> RNA samples obtained using procedures lacked detectable                            CPR Mutants <br /> genomic DNA assayed control PCR tests. The &#239;&#172;?rst-strand cDNA <br /> was synthesized using ThermoScript RT-PCR oligo(dT)                        pNiiA-CPR mutants grown AMM plus nitrate (In) AMM <br /> primers (Invitrogen, http://www.invitrogen.com) according                         plus ammonium (Re) 37 8C 20 h, total RNA extracted <br /> manufacturer&#226;&#8364;&#8482;s instructions. Double-strand cDNAs ampli-                        normalized. To monitor ensure sample loading, RT- <br /> &#239;&#172;?ed &#239;&#172;?rst-strand cDNA PCR using set gene-                          PCRs ACT1 transcript performed using identical <br /> speci&#239;&#172;?c forward reverse primers (Table S1). A typical PCR                            samples (unpublished data). Standard PCR performed to <br /> program following: 94 8C 2 min, 1 cycle; 94 8C 30 s, 60                con&#239;&#172;?rm detectable genomic-DNA contamination <br /> 8C 30 s 72 8C 2 min, 16 20 cycles; extension                  (unpublished data). <br /> 72 8C 10 min. PCR products subject 1% agarose-gel                       Found doi:10.1371/journal.ppat.0030024.sg002 (197 KB PPT). <br /> analysis. <br />    To perform real-time RT-PCR, total RNA samples extracted                          Figure S3. Normal Hyphal Growth pNiiA-CPR Mutants under <br /> and treated Turbo-DNase (Ambion), &#239;&#172;?rst-strand cDNA                          Inducing Conditions <br /> was synthesized described above. Real-time PCR                               To compare terminal phenotypes characterized Figure 4, pNiiA- <br /> performed using ABI 7500 thermocycler (Applied Biosystems, <br />                                                                                          CPR mutants GFA1, TUB1, SEC31, SLY1, ERG10, HEM15, PRI1, and <br /> http://www.appliedbiosystems.com). Reactions containing cDNA, for- <br />                                                                                          FKS1 grown AMM plus nitrate (inducing conditions) 30 8C <br /> ward reverse primers, &#239;&#172;&#8218;uorescent probe (integrated DNA <br /> technologies, invasive aspergillosis, applied biosystems; Table                  2 d. Micrographs taken microscope a <br /> S2) TaqMan Master Mix run triplicate using standard                      magni&#239;&#172;?cation approximately 380. <br /> conditions suggested manufacturer. When possible, primers                         Found doi:10.1371/journal.ppat.0030024.sg003 (299 KB PPT). <br /> and probes speci&#239;&#172;?cally designed cross adjacent exons avoid <br /> ampli&#239;&#172;?cation trace genomic DNA. The mean threshold cycle value                        Table S1. Primers Used pNiiA Cassette Construction, Northern <br /> (Ct) sample used calculate cDNA abundance                          Blot, RT-PCR <br /> inducing repressing growth conditions, samples                               Found doi:10.1371/journal.ppat.0030024.st001 (35 KB DOC). <br /> normalized based total input RNA previously described [43]. <br /> Changes expression calculated relative Ct gene                   Table S2. Forward Reverse Primers Probes Used Real- <br /> expressed wild-type strain.                                                         Time RT-PCR <br />    Northern blot analysis. Northern blot analysis carried                        Found doi:10.1371/journal.ppat.0030024.st002 (26 KB DOC). <br /> according established procedures [14,15]. Brie&#239;&#172;&#8218;y, total fungal RNA <br /> was prepared using RNeasy plant mini kit (Qiagen) according to <br /> the manufacturer&#226;&#8364;&#8482;s instructions. From 5 10 lg total RNA                        Acknowledgments <br /> used sample. P32-labeled ALR1 ACT1 probes made <br /> from PCR products ampli&#239;&#172;?ed using gene-speci&#239;&#172;?c primers (Table S1).                        We like especially thank Dr. Christophe d&#226;&#8364;&#8482;Enfert (Institut <br />    Drug susceptibility testing. MIC testing antifungal drugs                  Pasteur) kindly providing pyrG-containing plasmid and <br /> A. fumigatus wild-type strain CEA10 conditional mutants                              corresponding strains (CEA10 CEA17) Dr. Howard Bussey <br /> constructed promoter replacement performed broth                             helpful advice project. We thank Dr. Cameron <br /> microdilution described National Committee Clinical                        Douglas technical help real-time RT-PCR critical <br /> Laboratory Standards minor modi&#239;&#172;?cations [44]. The A. fumigatus                      review helpful suggestions manuscript. We thank <br /> inoculum adjusted concentrations approximately 2 3 103                         Drs. William Nierman, Malcolm Whiteway, Deming Xu, Roberto <br /> conidiospores/ml AMM, aliquot 0.1 ml added                           Rodriguez-Suarez critical review helpful suggestions <br /> microtiter wells containing 0.1 ml antifungal drug solutions                       manuscript. <br /> AMM. For inducing conditions, AMM plus 10 mM Mg(NO3)2 used.                             Author contributions. W. Hu T. Roemer conceived and <br /> To sensitize CPR mutants, ammonium tartrate added AMM                         designed experiments wrote paper. W. Hu, S. Sillaots, J. <br /> plus 10 mM nitrate &#239;&#172;?nal concentration 10 160 lM. The <br />                                                                                          Davison, S. Kauffman, A. Breton, A. Linteau, C. Xin, J. Bowman <br /> microtiter plate incubated 37 8C 48 h, MICs were <br />                                                                                          performed experiments. W. Hu, S. Lemieux, S. Kauffman, J. <br /> determined lowest concentration completely inhibited <br /> mycelia growth.                                                                          Bowman, J. Becker, B. Jiang, T. Roemer analyzed data. S. <br />                                                                                          Lemieux, J. Becker, B. Jiang contributed reagents/materials/ <br />                                                                                          analysis tools. <br /> Supporting Information                                                                      Funding. This study supported grant Genome <br />                                                                                          Canada Genome Quebec. <br /> Figure S1. Microscopic Analysis pNiiA-nudC Terminal phenotypes                           Competing interests. W. Hu, S. Sillaots, S. Lemieux, J. Davison, A. <br /> (A) Phase contrast microscopy (3160) demonstrates normal hyphal                          Breton, A. Linteau, C. Xin, J. Bowman, B. Jiang, T. Roemer are <br /> growth pNiiA-nudC mutants incubated inducing conditions                         current previous employees Merck &amp; Co., Inc. Elitra <br /> (16 h 30 8C).                                                                         Phamarceuticals Inc. S. Kauffman J. Becker consultants to <br /> (B) Phase contrast microscopy demonstrates pNiiA-nudC conidia                            Elitra Phamarceuticals Inc. <br />  <br />  <br /> References                                                                               4. Latge JP (1999) Aspergillus fumigatus aspergillosis. Clin Microbiol Rev 12: <br /> 1. Latge JP (2001) The pathobiology Aspergillus fumigatus. Trends Microbiol              310&#226;&#8364;&#8220;350. <br />    9: 382&#226;&#8364;&#8220;389.                                                                           5. Steinbach WS, Latge&#194;&#180; JP, Stevens DA (2005) Advances aspergillosis. <br />                                                                                             Med Mycol 43: S1. <br /> 2. Tekaia F, Latge JP (2005) Aspergillus fumigatus: Saprophyte pathogen?              6. Giaever G, Chu AM, Ni L, Connelly C, Riles L, et al. (1999) Genomic <br />    Curr Opin Microbiol 8: 385&#226;&#8364;&#8220;392.                                                          pro&#239;&#172;?ling drug sensitivities induced haploinsuf&#239;&#172;?ciency. Nat Genet 21: <br /> 3. Singh N, Paterson DL (2005) Aspergillus infections transplant recipients.             278&#226;&#8364;&#8220;283. <br />    Clin Microbiol Rev 18: 44&#226;&#8364;&#8220;69.                                                         7. Ross-Macdonald P, Coelho PS, Roemer T, Agarwal S, Kumar A, et al. (1999) <br />  <br />  <br />        PLoS Pathogens | www.plospathogens.org                                     0014                                         March 2007 | Volume 3 | Issue 3 | e24 <br />                                                                                                                                                    A. fumigatus Essential Gene <br />  <br />       Large-scale analysis yeast genome transposon tagging gene                       Discovering modes action therapeutic compounds using genome- <br />       disruption. Nature 402: 413&#226;&#8364;&#8220;418.                                                              wide screen yeast heterozygotes. Cell 116: 121&#226;&#8364;&#8220;137. <br /> 8.    De Backer MD, Nelissen B, Logghe M, Viaene J, Loonen I, et al. (2001) An                27.   Galagan JE, Calvo SE, Cuomo C, Ma LJ, Wortman JR, et al. (2005) <br />       antisense-based functional genomics approach identi&#239;&#172;?cation genes                       Sequencing Aspergillus nidulans comparative analysis A. fumigatus <br />       critical growth Candida albicans. Nat Biotechnol 19: 235&#226;&#8364;&#8220;241.                          A. oryzae. Nature 438: 1105&#226;&#8364;&#8220;1115. <br /> 9.    Uhl MA, Biery M, Craig N, Johnson AD (2003) Haploinsuf&#239;&#172;?ciency-based                     28.   Beauvais A, Latge JP (2001) Membrane cell wall targets Aspergillus <br />       large-scale forward genetic analysis &#239;&#172;?lamentous growth diploid                      fumigatus. Drug Resist Update 4: 38&#226;&#8364;&#8220;49. <br />       human fungal pathogen C. albicans. EMBO J 22: 2668&#226;&#8364;&#8220;2678.                                29.   Zheng Y, Cerione R, Bender A (1994) Control yeast bud-site assembly <br /> 10.   Bruno VM, Kalachikov S, Subaran R, Nobile CJ, Kyratsous C, et al. (2006)                      GTPase Cdc42. Catalysis guanine nucleotide exchange Cdc24 and <br />       Control C. albicans cell wall damage response transcriptional                       stimulation GTPase activity Bem3. J Biol Chem 26: 2369&#226;&#8364;&#8220;2372. <br />       regulator Cas5. PLoS Pathog 2: e21. doi:10.1371/journal.ppat.0020021                    30.   Ozaki K, Tanaka K, Imamura H, Hihara T, Kameyama T, et al. (1996) <br /> 11.   Roemer T, Jiang B, Davison J, Ketela T, Veillette K, et al. (2003) Large-scale                Rom1p ROM2p GDP/GTP exchange proteins (GEPs) Rho1p <br />       essential gene identi&#239;&#172;?cation Candida albicans applications                          small GTP binding protein Saccharomyces cerevisiae. EMBO J 15: 2196&#226;&#8364;&#8220; <br />       antifungal drug discovery. Mol Microbiol 50: 167&#226;&#8364;&#8220;181.                                         2207. <br /> 12.   Firon A, Beauvais A, Latge JP, Couve E, Grosjean-Cournoyer MC, et al.                   31.   Diaz-Guerra TM, Mellado E, Cuenca-Estrella M, Rodriguez-Tudela JL (2003) <br />       (2002) Characterization essential genes parasexual genetics                      A <span id='am-159' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-160' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-161' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-165' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-168' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-176' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-177' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-179' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-182' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-187' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-188' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-193' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-202' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-205' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-210' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-213' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-233' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-234' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-236' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span>point mutation</span> 14alpha-sterol demethylase gene cyp51A contrib- <br />       human fungal pathogen Aspergillus fumigatus: Impact genomic rearrange-                     utes itraconazole resistance Aspergillus fumigatus. Antimicrob Agents <br />       ments associated electroporation DNA. Genetics 161: 1077&#226;&#8364;&#8220;1087.                        Chemother 47: 1120&#226;&#8364;&#8220;1124. <br /> 13.   Firon A, Villalba F, Beffa R, D&#226;&#8364;&#8482;Enfert C (2003) Identi&#239;&#172;?cation essential              32.   Mann PA, Parmegiani RM, Wei SQ, Mendrick CA, Li X, et al. (2003) <br />       genes human fungal pathogen Aspergillus fumigatus transposon                        Mutations Aspergillus fumigatus resulting reduced susceptibility to <br />       mutagenesis. Eukaryot Cell 2: 247&#226;&#8364;&#8220;255.                                                        posaconazole appear restricted single amino acid the <br /> 14.   Mouyna I, Henry C, Doering TL, Latge JP (2004) Gene silencing RNA                        cytochrome P450 14alpha-demethylase. Antimicrob Agents Chemother 47: <br />       interference human pathogenic fungus Aspergillus fumigatus. FEMS                       577&#226;&#8364;&#8220;581. <br />       Microbiol Lett 237: 317&#226;&#8364;&#8220;324.                                                            33.   Nascimento AM, Goldman GH, Park S, Marras SA, Delmas G, et al. (2003) <br /> 15.   Romero B, Turner G, Olivas I, Laborda F, De Lucas JR (2003) The Aspergillus                   Multiple resistance mechanisms Aspergillus fumigatus mutants with <br />       nidulans alcA promoter drives tightly regulated conditional gene expression                   high-level resistance itraconazole. Antimicrob Agents Chemother 47: <br />       Aspergillus fumigatus permitting validation essential genes                     1719&#226;&#8364;&#8220;1726. <br />       human pathogen. Fungal Genet Biol 40: 103&#226;&#8364;&#8220;114. <br />                                                                                               34.   Colot HV, Park G, Turner GE, Ringelberg C, Crew CM, et al. (2006) A high- <br /> 16.   Vogt K, Bhabhra R, Rhodes JC, Askew DS (2005) Doxycycline-regulated <br />                                                                                                     throughput <span id='am-549' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-550' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-551' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-552' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-553' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-554' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-555' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-556' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-557' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-558' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-559' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-560' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-561' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-562' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-563' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-564' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-565' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-566' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-567' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-568' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-569' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-570' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-571' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-572' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-573' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-574' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-575' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-576' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-577' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-578' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-579' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-580' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-581' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-582' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-583' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-584' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-585' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-586' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-587' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-588' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-589' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-590' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-591' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-592' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-593' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-594' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-595' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-596' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-597' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-598' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-599' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-600' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-601' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-602' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-603' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-604' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-605' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-606' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-607' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-608' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-609' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-610' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-611' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-612' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-613' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-614' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-615' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-616' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-617' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-618' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-619' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-620' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-621' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-622' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-623' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-624' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-625' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-626' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span>gene knockout</span> procedure Neurospora reveals functions for <br />       gene expression opportunistic fungal pathogen Aspergillus fumigatus. <br />                                                                                                     multiple transcription factors. Proc Natl Acad Sci U S A 103: 10352&#226;&#8364;&#8220;10357. <br />       BMC Microbiol 5: 1&#226;&#8364;&#8220;11. <br />                                                                                               35.   Krappmann S, Sasse C, Braus GH (2006) Gene targeting Aspergillus <br /> 17.   Amaar YG, Moore MM (1998) Mapping nitrate-assimilation gene <br />                                                                                                     fumigatus homologous recombination facilitated nonhomologous <br />       cluster (crnA-niiA-niaD) characterization nitrite reductase gene <br />                                                                                                     end-joining&#226;&#8364;&#8220;de&#239;&#172;?cient genetic background. Eukaryot Cell 5: 212&#226;&#8364;&#8220;215. <br />       (niiA) opportunistic fungal pathogen Aspergillus fumigatus. Curr Genet <br />                                                                                               36.   da Silva Ferreira ME, Kress MR, Savoldi M, Goldman MH, Hartl A, et al. <br />       33: 206&#226;&#8364;&#8220;215. <br />                                                                                                     (2006) The akuB(KU80) mutant de&#239;&#172;?cient nonhomologous end joining is <br /> 18.   Muro-Pastor MI, Gonzalez R, Strauss J, Narendja F, Scazzocchio C (1999) <br />       The GATA factor AreA essential chromatin remodelling                              powerful tool analyzing pathogenicity Aspergillus fumigatus. <br />       eukaryotic bidirectional promoter. EMBO J 18: 1584&#226;&#8364;&#8220;1597.                                      Eukaryot Cell 5: 207&#226;&#8364;&#8220;211. <br /> 19.   Tsai HF, Wheeler MH, Chang YC, Kwon-Chung KJ (1999) A developmen-                       37.   Nakayama H, Izuta M, Nakayama N, Arisawa M, Aoki Y (2000) Depletion of <br />       tally regulated gene cluster involved conidial pigment biosynthesis                     squalene synthase (ERG9) gene does impair growth Candida <br />       Aspergillus fumigatus. J Bacteriol 181: 6469&#226;&#8364;&#8220;6477.                                            glabrata mice. Antimicrob Agents Chemother 44: 2411&#226;&#8364;&#8220;2418. <br /> 20.   Nierman WC, Pain A, Anderson MJ, Wortman JR, Kim HS, et al. (2005)                      38.   Nakayama H, Nakayama N, Arisawa M, Aoki Y (2001) In vitro vivo <br />       Genomic sequence pathogenic allergenic &#239;&#172;?lamentous fungus                           effects 14alpha-demethylase (ERG11) depletion Candida glabrata. <br />       Aspergillus fumigatus. Nature 438: 1151&#226;&#8364;&#8220;1156.                                                 Antimicrob Agents Chemother 45: 3037&#226;&#8364;&#8220;3045. <br /> 21.   Kurtz MB, Heath IB, Marrinan J, Dreikorn S, Onishi J, et al. (1994)                     39.   d&#226;&#8364;&#8482;Enfert C (1996) Selection multiple disruption events Aspergillus <br />       Morphological effects lipopeptides Aspergillus fumigatus correlate                 fumigatus using orotidine-59-decarboxylase gene, pyrG, unique <br />       activities (1,3)-beta-D-glucan synthase. Antimicrob Agents                       transformation marker. Curr Genet 30: 76&#226;&#8364;&#8220;82. <br />       Chemother 38: 1480&#226;&#8364;&#8220;1489.                                                                40.   Cove DJ (1966) The induction repression nitrate reductase the <br /> 22.   Mellado E, Diaz-Guerra TM, Cuenca-Estrella M., Rodriguez-Tudela JL                            fungus Aspergillus nidulans. Biochim Biophys Acta 113: 51&#226;&#8364;&#8220;56. <br />       (2001) Identi&#239;&#172;?cation different 14-alpha sterol demethylase-related               41.   Verdoes JC, Punt PJ, van der Berg P, Debets F, Stouthamer AH, et al. (1994) <br />       genes (cyp51A cyp51B) Aspergillus fumigatus Aspergill <br /> </body></html>